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Jennifer Rose Moeller, M.S. 
University of Pittsburgh, 2009
 
Research Aims:  Many studies have identified an association between cardiovascular disease 
and periodontal disease.  Awareness is growing that oral health is important in an individual’s 
general health.  There is evidence suggesting that oral conditions, such as dental caries and 
periodontal disease, are due to bacteria contained in plaque and treatable, possibly preventable 
conditions.  The aims of this study are 1) determine if there is a familial correlation in the ability 
to host supragingival and subgingival bacteria, 2) determine familiality in the development of 
dental caries and periodontal disease, and 3) if there is a familial correlation, propose 
modifications to the oral health hygiene standard of care that may influence the development of 
oral disease, which in turn may lower the risk of developing cardiovascular disease. 
Methods:  Data were obtained from the COHRA study (IRB #020773 and #0506048).  
Participants (n = 2,570) contacted the study coordinator and attended a clinic at which DNA 
samples were obtained, dental examinations were performed, and questionnaires were 
completed.  FCOR, a S.A.G.E. statistical program, was used to analyze the data and determine 
the familial correlation between relative pair-types. 
Results:  The influences of environment and genetic make-up in regards to oral health, 
specifically the ability to host bacteria and the development of dental caries and periodontal 
disease, are complex.  The correlations of all pair-types were similar and likely overlap when the 
standard error is considered.   
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Conclusion:  Results suggested that there was no strong evidence of a genetic influence on the 
ability to host supragingival or subgingival bacteria or the development of dental caries or 
periodontal disease.  However, the amount of influence environment and genetic factors have in 
the development of oral disease remains unclear. 
Public Health Significance:  The relationship between cardiovascular disease and periodontal 
disease is not understood.  A continuated attempt to understand the components of oral disease 
status and its influence on cardiovascular disease may provide an avenue by which to decrease 
an individual’s risk to develop cardiovascular disease.   
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1.0  BACKGROUND AND SIGNIFICANCE 
Oral health has been shown to have significant importance to the overall health of an individual.  
The mouth can serve as a window and allow us to examine what diseases are already occurring 
in the body, such as HIV/AIDS and diabetes mellitus, or what a person may be at risk for in the 
future, such as stroke or heart disease 1.  The presence of bacteria-containing subgingival plaque, 
which is associated with periodontal disease, has been correlated with an increased risk of 
cardiovascular disease 2.  Infection was thought to be a risk factor for cardiovascular disease over 
100 years ago 3, but scientific investigation into such an idea only began a little over 15 years 
ago 4.  There is still a debate as to the type of association between periodontal disease and 
cardiovascular disease: causal or correlative.  Identification, evidence, and classification of an 
association are complicated by the complexity of quantifying measurements for each of the 
diseases.  The lack of standard definitions of exposures, periodontal disease, and outcomes has 
also added to the difficulty in assessing the type of association 3.  Many studies support and 
provide evidence that there is at least some association between periodontal disease and 
cardiovascular disease, though the nature is still unclear.  The association appears to be a positive 
correlation; an increase in the amount of plaque-containing bacteria increases the risk of 
cardiovascular disease.   
Many advances have been made in the area of oral health and oral hygiene.  In the 1920s, 
observations of plaque growth and dental decay lead to the recommendation of tooth brushing 
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and annual or semiannual cleanings by a dentist in the attempt to reduce plaque growth 5.  It was 
thought that plaque itself was the cause of dental decay, known as the non-specific plaque 
hypothesis.  In the 1960s, fluoride was added to toothpaste in an attempt to stop the oral decay 
that was being observed.  In 1976, the specific-plaque hypothesis was proposed by Loesche 6, 
who asserted that Streptococci mutans played a unique role in dental decay.  Today, we 
understand that dental caries, periodontal infections, and tongue conditions are associated with 
unique plaque containing specific bacteria, such as Porphyromonas gingivalis 7, and that these 
bacteria may be involved in other systemic conditions. 
Subgingival plaque, which is associated with periodontal disease 5; 8 and an increased risk 
for cardiovascular disease, can be identified by a professional and controlled through treatment.  
Supragingival plaque, which is associated with the development of dental caries and tooth decay, 
may be involved in the development of subgingival plaque.  This plaque can also be controlled 
through treatment and thus, reduce the risk of dental caries, tooth decay, and subgingival plaque 
5.   
It is clear that many complex diseases, including periodontal disease, have a genetic basis 
9.  Oral health has seen anecdotal evidence of a genetic basis.  Multiple patients report, “Bad 
gums run in my family” or “My mother had chalky teeth too” 10.  Periodontal disease has also 
been observed to aggregate within families 9.  There are other factors involved, such as 
environment, microbes, and behavior that can also be transmitted through families from parent to 
child.  Identifying the familiality in the presence and levels of supragingival and subgingival 
bacteria-hosting plaque may provide a first step in treatment and early intervention protocols for 
systemic disease.  It would aid in developing recommendations for the appropriate standard of 
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care to individuals and their families.  These interventions may benefit a patient through both 
their oral health and their cardiovascular health.   
1.1 DENTAL CARIES 
Dental caries is one of the most common oral diseases 10 and is caused by the bacterial 
fermentation of sugars and other dietary carbohydrates which lead to the decay of tooth mineral 
5.  Bacteria that are a part of the normal human flora of the tooth respond to the amount of 
dietary sugars being introduced and begin to grow and expand on the tooth surface in which they 
cover.  As the bacteria metabolize the sugars, the plaque becomes more acidic, causing the tooth 
to become the buffer and release calcium and phosphate ions.  If these minerals are not replaced, 
a loss of tooth substance occurs and a white spot lesion forms.  This is the beginning stage of 
dental caries.  As the condition progresses, the bacteria penetrate the enamel crystalline and the 
underlying dentine.  Cavitation is a late event in the dental caries process.   
 
Figure 1 Stages of the development of dental caries 11 
Currently, dental caries are seen as multifactorial based upon host, microbial, and 
environmental factors 10.  It is thought that influences of all of these components play a role in 
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the development of dental caries and decay.  Recently, studies have suggested that there is 
approximately a 50% genetic contribution to the development of dental caries 10.  As shown in 
the figure below, genetic contributions are not being included in the multifactorial model as of 
yet. 
 
Figure 2 Dental caries as a multifactorial condition 12 
1.1.1 Bacteria involved in dental caries 
Mutans streptococci include the bacteria S mutans and Streptococcus sobrinus.  The majority of 
the time, these bacteria are referred to in tandem and are identified as mutans streptococci.   
S mutans were identified as a cause for dental caries using rodent models in the 1960s 10.  
The association to human dental decay was uncertain given that mutans streptococci are dental 
pathogens typically found on the human teeth.   
 4 
1.2 PERIODONTAL DISEASE 
Periodontitis is a widespread condition due to a chronic bacterial infection 7; 13; 14.  These bacteria 
invoke a chronic inflammatory response that results in the destruction of connective tissue and 
bone of the dentition 15.  By the age of 12 years, 40% of the population is found to have moderate 
periodontitis.  Of those over 65 years of age, 80% are found to have moderate periodontal 
destruction 13.  Many of the signs of periodontal disease include tooth loss, gingivitis, periodontal 
bleeding and  inflammation, excess plaque, infection, decay, tooth mobility, gum recession, and 
bone loss 16.  Not all individuals with periodontal disease will show warning signs or symptoms 
of the disease 17. 
 
Figure 3 Common signs of periodontal disease 16 
Periodontal disease has been found to be associated with multiple systemic conditions, 
such as airway obstruction 15, cardiovascular disease 3; 4; 7; 14, and diabetes 7.  Low birthweight of 
babies has also been associated with the presence of periodontal disease in the mother 14.  The 
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relationship between systemic conditions and periodontal disease, and their pathways are still 
under investigation 7.  
Evidence suggests that a majority of the diseases seen today have a genetic basis, 
including periodontal disease 9.  The development of periodontal disease is under many 
influences, such as microbial, environmental, behavioral and genetic 9; 14.  In a study by Yang et. 
al, 18 – 48 month old daughters of mothers with periodontitis have 5.8 times the odds for 
Bacteroides forsythus, a bacterial species associated with periodontal disease, than those age 
matched daughters of mother without periodontitis 18.  This study supports the thought that there 
is likely to be a familial correlation in the ability to host oral bacteria associated with periodontal 
disease.  Kinane et. al. has suggested that aggressive periodontal disease is inherited in an 
autosomal dominant pattern with reduced penetrance 9.  This indicates a near 50% risk of 
developing the disease for first-degree relatives of those with periodontal disease.  Hart et. al. 
suggested through a literature review that while microbial factors are required for periodontal 
disease to develop, they do not predict the severity or even the presence of disease 14.  Systemic 
factors also affect the disease risk and progression by their effects on the immune and 
inflammatory response of the individual 7.  It is clear that the response put forth by the body is 
influenced by the obviously complex interactions between all of these components 7; 14.  It is also 
clear that these components are broadly transmissible through families. 
Many studies have shown the aggregation of periodontal disease through families, 
suggesting a genetic component being transmitted 9; 13.  The underlying component may be due 
to changes on the DNA level, such as a nucleotide change 9.  This change is known as a genetic 
polymorphism.  A genetic polymorphism may alter the function of the gene or its product, but is 
less disruptive than a mutation, a harmful change.  The product may be changed slightly, which 
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alters its interactions with other genes, gene products, environment, and body responses to 
predispose or protect an individual.  Genetic polymorphisms can be passed through the family 
from generation to generation and may provide some explanation to the familial aggregation 
seen.   
1.2.1 Bacteria involved in periodontal disease  
Subgingival bacteria initially colonize in the supragingival plaque 5.  These bacteria 
become anaerobic and move beneath the gingival margin where there is a lower pressure of 
oxygen tensions.  Certain bacteria detected within the mouth have been reported to be involved 
in the progression of periodontitis.  In a study by Yang et. al, Bacteroides forsythus (now known 
as Tannerella forsythensis) was found to be significant associated with the progression of 
periodontal disease, whereas Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans 
were not 18.  Tuite-McDonnell et. al. presented results indicating that children of parents with 
colonized Porphyromaonas gingivalis, which is associated with periodontitis indicators such as 
deep pockets and loss of attachment, are at a greater risk of colonizing P. gingivalis 13.  
Potentially, the presence of Porphyromonas gingivalis, Treponema denticola, Tannerella 
forsythensis (Bacteriodes forsythus) in combination with genetic markers may be able to predict 
periodontal disease severity 19.   
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1.3 CARDIOVASCULAR DISEASE 
According to the American Heart Association, 80 million individuals were known to have one or 
more forms of cardiovascular disease in the year 2006.  Cardiovascular disease was also the 
reported final cause of death in 1 out of 2.8 deaths in 2005 20.  In developed countries, coronary 
heart disease is the leading cause of death and morbidity, killing more than 7 million people 
worldwide per year 16.  Coronary artery disease is the major cause of premature death among 
men 7.  Cardiovascular disease has great implications for an individual’s quality of life and the 
financial responsibilities of an individual and society 14. The economic cost of cardiovascular 
disease and stroke in 2008 was $475.3 billion, which includes costs such as physicians and 
hospitals and loss of productivity.  The cost is thought to be even greater after inclusion of the 
immeasurable costs of suffering and the loss of human lives 20.   
There are many known risk factors for heart disease.  Some risk factors can be changed 
or eliminated to adjust an individual’s risk of heart disease such as smoking, high blood pressure, 
high blood cholesterol, diabetes, being overweight or obese, poor diet and exercise 21.  Some risk 
factors, however, cannot be changed and include age, gender, and family history 22.  Oral health 
is being acknowledged more commonly as a risk factor for cardiovascular disease 1-5; 7; 16; 23-25.   
The genetic basis for cardiovascular disease has been difficult to study given the variable 
expressivity and complex nature of the disease itself 14.  This has caused a lack in a complete 
understanding of the disease.  However, the ability to study such complex diseases is changing 
and may produce a new understanding and ability to intervene with these conditions.   
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1.4 ORAL HEALTH AND CARDIOVASCULAR HEALTH 
Chronic infection is recognized as being a potential instigator in the development of systemic 
diseases, including cardiovascular disease 7; 16; 19; 26.  In individuals under the age of 50 years, 
missing teeth due to periodontal inflammation was associated with multiple medical conditions, 
as seen in Table 1 5.  Periodontal bone loss has been associated with increased odds of coronary 
artery disease (1.5), fatal coronary heart disease (1.9), and stroke (2.8) relative to appropriate 
comparison groups.  Humphrey et al. showed that periodontal disease was associated with a 24-
35% increase in risk for coronary heart disease 16.   
Table 1 Medical conditions in which dental infections may be contributory 5 
Medical condition    Dental risk indicator   
 Preterm births    Periodontal infections (gram-negative anaerobes)   
 Cerebral vascular accident    Periodontal infections (gram-negative anaerobes)   
 Coronary artery disease    Periodontal infections (gram-negative anaerobes); Tooth loss 
 Diabetes    Periodontal infections (gram-negative anaerobes)   
 Alzheimer’s disease    Tooth loss before age 35 years   
 
Continued investigation into the causality and pathways between periodontal disease and 
cardiovascular disease is necessary.  The importance of other microbes present 26 or other 
systemic conditions identified in the individual 7 is unclear.  The interactions between oral 
infection, cardiovascular disease, genetic influences and body responses are also unclear and 
require more investigation.  In 2004, Janket et. al. presented a diagram of potential pathways 
associating oral health with systemic health 27, which can be found below. 
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 Figure 4 Hypothetical diagram of pathways linking oral and cardiovascular health 27 
1.4.1 Bacteria and its association with oral health and cardiovascular health  
Porphyromonas gingivalis is bacteria specific to the oral cavity 27.  It has been linked with 
indicators of periodontal disease, such as deep pockets and attachment loss 13; 28.  Many studies 
have found specific antibodies of that bacteria in atherosclerotic plaques of patients with 
periodontal disease 27.  The detection of those bacteria in that location suggests that periodontal 
disease may be linked with cardiovascular disease.  Other studies have shown that these bacteria 
have the ability to invade endothelial cells in vitro 7.  It is thought that this invasion may be an 
initiating factor or alter the progression of arthrosclerosis, a factor in cardiovascular disease. 
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1.5 CURRENT TREATMENT OPTIONS FOR DENTAL CARIES AND 
PERIODONTAL DISEASE 
Even in the presence of oral disease, a microbial sample is rarely taken and confirmed 5.  The 
knowledge of the underlying microbial infection would not change the treatment the patient 
receives because treatment is determined in response to the symptoms presented by the patient.  
However, research has shown evidence that dental caries and periodontal disease have a genetic 
basis.  Therefore, some individuals may be predisposed or have a greater likelihood to host these 
bacteria leading to poor oral health.  Current treatment options do not take genetic variations and 
their implications into account, but are similar for all individuals. 
The current paradigm of disease treatment is not designed to account for the multitude of 
genetic information known to impact our oral health 14.  It may be time for another adjustment in 
our view and paradigm of oral health and disease treatment.  Knowledge of a genetic 
predisposition and/or a family correlation to host bacteria associated with dental caries and 
periodontal disease could allow for prophylactic treatment options for patients and their families.  
Not only could these treatments include prophylactic screening and treatment for dental caries 
and periodontal disease, but research has suggested treatment to reduce or prevent the presence 
of oral bacteria may have results impacting their cardiovascular health as well 2; 7; 24; 26. 
Currently, the standard of care is to brush with fluoride toothpaste twice a day, floss once 
a day, eat a balanced diet with limited snacking, and attend regularly scheduled visits with a 
dentist for an examination and cleaning 8.  Fluoride has been added to the drinking water of 
many cities and to the toothpaste available to consumers.  Fluoride has an anti-microbial effect at 
acidic pH levels, allowing the tooth to dissolve and decay at a slower rate than without fluoride 5.  
Periodontal disease can be treated by removing the debris from the tooth surface and with a 
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systemic antibiotic 5.  Seeing a dentist regularly allows early signs of periodontal disease to be 
detected so that a patient may begin treatment in the early stages.  Some of the signs that may be 
observed are: tooth loss, gingivitis, periodontal bleeding, gum inflammation, excess plaque, 
infection, decay, tooth mobility, gum recession, and bone loss 16.  It is possible, however, to not 
exhibit warning signs of disease 17.  For these individuals and those who have a greater 
likelihood to better host these bacteria, a new standard of care should be investigated. 
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2.0  AIMS OF THE STUDY 
2.1 AIM 1 
Determine if the ability to host supragingival bacteria (S. mutans) and subgingival bacteria 
(Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythensis (formally known 
as Bacteriodes forsythus)) within oral plaque has a genetic and/or familial component. 
2.1.1 AIM  1A 
Determine the family correlation between family members based on semi-quantitative measures 
of microbial infection using data from the Dentocult® test (supragingival plaque samples, caries 
related organisms) and the BANA™ test (subgingival plaque samples, periodontal disease-
related organisms). 
2.2 AIM 2 
Investigate familiality in the development of dental caries and periodontal disease. 
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2.2.1 AIM  2A 
Determine the family correlation between family members based on caries indicators (DMFT, 
DMFS) and periodontal disease indicators (probing depth, bleeding on probing). 
2.3 AIM 3 
If the family correlations are consistent with a significant genetic component, investigate 
possible modifications to current dental health recommendations. 
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3.0  METHODS AND PROCEDURES 
The COHRA study, from which these data were obtained, was initiated through a collaboration 
between Dr. Mary Marazita and Dr. Robert Weyant and approved by the Institutional Board of 
Review (Appendix B and Appendix D).  The data used in this research was collected from 2002 
until present.   
3.1 PROTOCOL SUMMARY 
Families with at least one child between the ages of 1 and 18 years of age living in West Virginia 
(80% of the participants) and Pennsylvania (20% of the participants) were invited to participate 
in the study through IRB-approved fliers, radio and television advertisements, and talks to 
schools and organizations (Appendix B).  If a family was interested in participating in the study, 
the prospective participant telephoned the study coordinator.  At that time, the primary care giver 
was identified as the index case, the research protocol was explained, and a screening interview 
was given to determine eligibility.  If the family fulfilled the eligibility criteria, the family and 
family members were given an ID number to preserve confidentiality.  Adults and children 
(Appendix B) in the family were invited to participate.  After the screening interview form was 
completed and eligibility was determined, an appointment was made for the family to attend the 
clinic and an information packet containing a welcome letter, a sample consent form, and vial to 
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collect a sample of the household water was provided.  At the time that they came in to the 
clinic, the family was consented.  Parents consented for themselves and their children.  The 
antibiotic screening form and the protocol were reviewed with the family to answer any 
additional questions.  At this time, family members were rotated through the research stations 
(i.e. questionnaires, dental examination, physical examination, and sample collection).  At the 
end of the procedure (approximately 4 hours), the participants were reimbursed $25 for each 
visit.  Children were reimbursed with a gift card made out in their name to avoid parental 
coercion to participate.  Follow-up appointments occur every 2 years for a total of 3 to 4 visits. 
3.2 INITIAL CONTACT OF INTEREST 
Prior to the participant’s first visit, they contacted a research coordinator by telephone and 
3.2.1 Screening interview form 
The screening survey focused on demographic information and was divided into four parts.  Part 
discussed the study protocol, study eligibility, and were given an ID number.  During this 
conversation, the participant was asked questions from a screening survey regarding 
demographic information to determine eligibility. 
1 asked information regarding how the participant learned about the project, their age and 
gender, and their ethnicity.  Part 2 obtained information regarding the participant’s household 
situation.  This included information such as where their home was located, how long they had 
lived at their home, how many individuals lived in the home with them, and how they were 
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related to those individuals.  This section of the survey also asked how many total vehicles were 
owned by individuals in the home as well as the total yearly income of the household.  Part 3 
asked participants about the type of home in which they lived, if they owned or rented their 
home, and the types of utilities they had, such as gas heat versus electric heat.   
The last section, part 4, was used to determine if a participant was to be excluded from 
the stu
3.3 VISIT 1 
3.3.1 Station 1 
3.3.1.1 Consent interview 
Before any other part of the study protocol was started, the participants were consented.  
At this time the consent forms (Appendix A and Appendix C) were explained and signed.  Each 
dy through questions regarding a reduced ability to fight infection, artificial joint 
replacement, or need to take medication before a dental examination.  If the participant answered 
“yes” or “suspects” to these questions, his/her case was reviewed by a select group of individuals 
at the Center for Craniofacial and Dental Genetics to determine if the individual was to be 
included in the study or if invasive sections of the dental examination were to be avoided.  Those 
individuals who were found to have neurologic impairment, a severe physical or intellectual 
handicap, or psychosis were excluded from the study.  In addition, households with an adult who 
required antibiotic pre-medication, but refused to take it, were excluded from the study.  
Children required to take antibiotic pre-medication for dental work were excluded from any 
invasive procedure that may cause bleeding.   
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individual participating in the study had to sign a consent form.  The protocol was explained and 
reviewed and participant questions are answered. 
3.3.1.2 Antibiotic Screening Form 
screening form, reviewed at the time of scheduling the appointment, 
was to
f the health risks 
associated with the antibiotic prophylaxes Amoxicillin and Clindamycin. 
3.3.1.3
out a set of self-report questionnaires in which 
they pr
.  Some questionnaires were 
not given to children because they were not applicable or their information was gathered through 
the survey of the parent. 
The purpose of this 
 identify those that require antibiotic pre-medication, have an inhibited ability to fight 
infection, or are at risk to develop infection.  These individuals were informed of the sections of 
the procedure that may have be to avoided if they refuse to adhere to the American Heart 
Association guidelines for pre-medication.  They were also informed o
 Collecting the household water sample 
During the phone conversation to set up an appointment, each family was asked to 
retrieve a sample of their drinking water with the vial provided in the packet mailed to them.  
This sample is stored by an IRB approved protocol for later studies. 
3.3.2 Station 2 
At station 2, study participants were asked to fill 
ovided demographic information, oral health history, and pregnancy history, if applicable, 
in addition to other information.  Each of these surveys focused on different aspects of the 
individual’s life that may be applicable or related to their oral health
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Table 2 Visit 1 Self-Report Questionnaires by Age Group 
Questionnaires Adult  14 – 17  11 – 13  
(18 + years) years years 
1 SF-36 Health Survey X X X 
2 DUSI-R (Screening Form) X X X* 
 DUSI-R X X*  
3 Fagerstrom Test for Nicotine Dependence X X X 
4 Fagerstrom Test for Smokeless Tobacco Use X X X 
5 Dental Fear and Anxiety Scale ** X X X 
6 Oral Health Impact Profile X X X 
7 Perceived Stress Scale X X X 
8 Fatalism Scale X X X 
9 Health Locus of Control X X X 
10 Parental Supervision and Involvement X X* X* 
11 Family Assessment Me X X asure (FAM)*** X 
 Section 1. General Scale (X) (X) (X) 
 Section 2. D p Scale yadic Relationshi (X) (X) (X) 
 Section 3. Self-Rating Scale (X) (X) (X) 
12 ISEL X X*  
13 West Virginia Identity Scale (WVIS)† X X  
     
 Parental Report Questionnaire‡  X X 
* Youth Version 
** A  and Anxiety Scale is col d on childre ged 1 – 10 t is 
eport form using the teleform syste
 T ut by participants aged 11 an der.  In Section 1, each participant 
rding their family in general.  Sectio  is a self-ra  scale.  Se n 2 
c relationships within families.  Each individ questions about ific 
t the FAM query sheets and fills ou e name of e  individua he 
llows: 1) Parents fill o  FAM quer et for eac ld.  
 sheet for each parent. 
ites 
‡ he P e is filled out by parents on all children aged 1  The version for 
3
NA collection via phlebotomy or Oragene™.  A blood sample collection was 
sample
collection were explained.  
 simplified version of the Dental Fear lecte n a .  I
administered as a parental r m. 
*** he FAM has 3 sections to be filled o
answers questions rega
d ol
n 3 ting ctio
assesses dyadi ual answers spec
relatives.  Staff takes ou t th ach l.  T
relationships to be documented are as fo ut a y she h chi
2) Child (aged 11 – 18) fill out a FAM query
e WVIS is used only at the West Virginia field s† Th
 T arental Report Questionnair – 18. 
children aged 1 – 10 is abbreviated. 
3.3.  Station 3 
At station 3, D
attemp le collection method.  Blood 
s were not able to be obtained from all participants.  Other methods of DNA sample 
ted on each participant and was the preferred DNA samp
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3.3.3.1
phlebotomist performed a venipuncture on participants aged 1 year and older and collected an 8 
3.3.3.3 Priority 3: Cheek swab samples preserved in Oragene™  
d nor “spit” saliva were able to be collected, cheek swabs 
were us
ity 4: Mouthwash samples 
Mouthwash buccal samples were taken only if all options above were not feasible.  
t least an hour after eating or drinking.  Participants spat 
mouthw
3.3.4 Station 4 
The Cl
mple 
collections in which results were documented on the dental screening form and supplement form 
 Priority 1: Blood collection 
Blood was the preferred DNA sample and was considered to be first priority.  A trained 
ml sample.   
3.3.3.2 Priority 2: Saliva samples 
Saliva samples were taken from those in whom blood was not retrieved.  These 
individuals were able to spit.  The sample was taken at least one hour after eating or drinking. 
In the case where neither bloo
ed to obtain a DNA sample.  Tips of the cheek swabs were preserved in Oragene™. 
3.3.3.4 Prior
Mouthwash samples were taken a
ash samples into a blue-topped conical tube. 
inical Dental Screening, conducted by a dentist or dental hygienist and dental assistant, 
was performed at station 4.  It included a dental screening and microbiological sa
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(Appendix F and Appendix G).  At the end of the screening, the study participant received a 
Clinica
l screening exam were omitted depending 
upon the study participant’s age. 
l Findings Report filled out by the dentist or dental hygienist performing the screening.   
As seen in Figure 5, certain procedures were deemed inappropriate or not applicable for 
children under a certain age.  Sections of the denta
 21 
 Figure 5 Eligibility criteria for dental screening exam procedures dependent upon age 
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3.3.4.1 Supragingival plaque sample and tongue scraping for microbiology culture & DNA 
analysis 
Dentocult® SM Strip mutans is a test that is used to determine the presence of mutans 
streptococci in plaque 29.  Plaque was removed from different locations of the tooth (TestR, 
SupTestR and Plaq) and placed on the square-ended wand provided with the kit.   
An additional sample at the same locations was collected in multicolored capped 
Eppendorf tubes. 
 
Table 3 Supragingival plaque samples 
Sample Number &  Instrument & method to use to  
Corresponding Dentocult® 
stick 
Type of Surface  collect sample region &/or Eppendorf tube 
Sample 1: Surfaces of intact  Swipe tooth surface with 
sterile  
“1” on Dentocult Strip &  
(sound) & caries-free enamel  Stimudent White Cap Eppendorf 
Sample 2: Surfaces of white  Obtain plaque by pooling  “2” on Dentocult Strip &  
spot lesion  material with sterile Gracey  Yellow Cap Eppendorf  
 1/2  
Sample 3: Surfaces of 
cavitated  
Obtain plaque by pooling  “3” on Dentocult Strip &  
initial enamel lesions  material with sterile Gracey  Orange Cap Eppendorf  
 1/2  
Sample 4: Carious dentin 
from  
Obtain plaque by pooling  “4” on Dentocult Strip &  
deep dentinal lesions  material with sterile Gracey  Red Cap Eppendorf  
 1/2  
Sample 5: Tongue scraping  Use 1 Stimudent to scrape the  Violet Cap Eppendorf (do 
not 
 tongue dorsum  collect on Dentocult strip)  
3.3.4.2 Stimulated saliva secretion rate 
The stimulated saliva collected from this procedure will be used in the Mutans 
Streptococci Test, Saliva Secretion Flow Rate, and Salivary Cotinine. 
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The individual was asked to chew on a piece of plan wax for one minute.  After that time, 
they were asked to remove the wax from their mouth and the excess saliva was used for the 
salivary cotinine test.  The round-ended wand provided in the kit was placed on their tongue ten 
times to identify mutans streptococci.  The two wands were then snapped together and placed in 
the incubation broth.   
The study participant performed the saliva secretion flow rate test by allow saliva to 
secret from their mouth and into a conical tube for three minutes. 
3.3.4.3 Soft tissue exam 
The dentist or dental hygienist visually inspected the mouth of the participant and 
documented all positive finding.  A box labeled “Other Diagnosis Description” was provided for 
those findings that did not fit in to those types provided on the document. 
3.3.4.4 Dentures assessment 
The dentures of the study participants, if applicable, were examined.  The type and 
location of the dentures were located on the examination form. 
3.3.4.5 Eligibility criteria for edentulous patients 
At this point in the dental exam, participants were determined to be completely 
edentulous, indicating that there were some sections of the dental exam that were not applicable 
to them, or not completely edentulous.  Only a BANA™ tongue sample and the throat swab were 
obtained from those who were completely edentulous. 
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3.3.4.6 BANA™ plaque and tongue scraping; subgingival plaque for microbial DNA 
Plaque samples from the mesio-buccal surfaces of four reference teeth were obtained 
from study participants.  Each tooth was sampled twice.  The reference teeth selected were the 
first molars on the maxilla (#3, 14) (Btest03 and Btest14) and mandible (#19, 30) (Btest19 and 
Btest30) (Figure 2).  One sample from each sample site was placed on a BANA-Zyme™ test 
strip and then placed into the provided incubator.  The other sample from each sample site was 
placed in green-topped Eppendorf tubes. 
 
Figure 6 American numbering system of permanent teeth 
A tongue scraping (TungRes) using a Stimudent was also performed to obtain a sample 
of the bacteria culture.  This sample was placed on a BANA-Zyme™ test strip and then placed 
into the provided incubator. 
Measurements of deep pockets in the gums (PSR03, PSR14, PSR19, PSR30), induction 
of bleeding with probing (BL03, BL14, BL19, BL30) and recession (REC03, RES14, RES19, 
RES30) (Periodontal Screening Record) were performed on each participant at each reference 
tooth used in the subgingival plaque sample collection. 
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3.3.4.7 Papillary bleeding score 
A Stimudent was placed between each tooth for the count of 15 seconds.  After 15 
seconds, the Stimudent was removed and an assessment of the gingival (bleeding, redness and 
irritation) was made and documented in the examination packet. 
Table 4 Loesche Papillary Bleeding Index 
Papillary Bleeding Index 
(PBI) Loesche  
Result of Stimudent Insertion  
0  Healthy gingival tissue; no bleeding upon insertion of Stimudent 
interproximally.  
1  Edematous, reddened gingival tissue; no bleeding upon insertion 
of Stimudent interproximally.  
2  Bleeding without flow along gingival margin upon insertion of 
Stimudent interproximally.  
3  Bleeding with flow along gingival margin upon insertion of 
Stimudent interproximally.  
4  
Copious bleeding upon insertion of Stimudent interproximally.  
5  Severe inflammation, marked redness and edema; tendency to 
spontaneous bleeding.  
9  One of the pair of teeth is missing.  
3.3.4.8 Periodontal screening record (PSR) in subjects > 17 years old 
Each tooth was examined individually using a periodontal probe for deep pockets (S1, 
S2, S3, S4, S4, S5, S6), recession (S1r, S2r, S3r, S4r, S5r, S6r), and bleeding upon probing (S1b, 
S2b, S3b, S4b, S5b, S6b).  The data was collected per sexton, as in Figure 7 below. 
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 Figure 7 Sextant for PSR Exam 
3.3.4.9 Malocclusion exam 
This exam was used to explain the four dimensions of a participant’s occlusion.  The 
measurements included overjet, overbite, open bite, and displacement.  An angles class was also 
determined for each participant. 
3.3.4.10 Caries exam 
A dentist or dental hygienist visually examined each surface of each tooth of the study 
participant.  The dentist or dental hygienist performing the examination called out observations 
using codes provided in Figure 8, regarding reconstruction of tooth surfaces and other visual 
observations to the dental assistant who documented those observations. 
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 Figure 8 Dental caries exam diagnosis code 
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3.3.4.11 Trauma exam 
The dentist or dental hygienist visually assessed the teeth of the participant for any signs 
of oral trauma, such as fractures or complete loss of teeth. 
3.3.4.12 Throat swab 
A long swab was used to collect a sample from the participant’s throat. 
3.3.5 Station 5 
At station 5, participants were interviewed by the research assistant or nurse regarding their oral 
health attitudes and behaviors using the Dental/Oral Health questionnaires. 
3.3.6 Station 6 
A trained nurse/medical examiner obtained a medical, family, and pregnancy (females only) 
history from the study participants at Station 6.  A physical exam was also performed at this 
station. 
3.4 STATISTICAL ANALYSIS 
3.4.1 Participant demographics 
The data used in these analyses were from the first visit only of each participant.  The 
participants were seen at three clinic sites in Pennsylvania: Braddock (7.67%), Bradford 
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(13.00%), and Burgettstown (14.02%), and clinic sites in West Virginia (65.14%), totaling 2,570 
study participants from 525 families.  Of those individuals, 1,139 were males (44.32%) and 
1,431 were females (55.68%).  The majority of the patient population was Caucasian (80.31%).  
Individuals identifying themselves as African American (6.50%), Hispanic (0.82%), Asian 
(0.27%), Native American/Alaskan Native (0.16%), and “Other” (1.17%) also participated in the 
study.  Some of the participants neglected to indicate a representative race (10.78%).   
Information regarding relationship to other participants, sex and race were obtained using 
the initial intake form and screening interview form.  Biological information was provided by the 
dental examination packet filled out by the dental hygienist and assistants throughout the 
appointment. 
3.4.2  S.A.G.E. 
The data collected in this study were organized into to a data set including a family ID, 
individual ID, sex, race, and the data listed in Tables 4 and 5.  The FCOR program of the 
S.A.G.E. (Statistical Analysis for Genetic Epidemiology) package was used to identify any 
familial correlations within the data.   
S.A.G.E. contains multiple C++ programs used in genetic analysis.  The FCOR program 
was used to estimate a family correlation for pair types, such as parent-parent, parent-child, and 
sibling-sibling, for the variables of interest.  FCOR uses the equation in Figure 9 below to 
calculate the correlation between the pairs.   
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 Figure 9 Correlation equation 30 
S.A.G.E. used the data which was organized into pedigrees based upon assigned family 
ID and individual ID.  FCOR analyzed pairs to determine correlations between family members 
regarding the traits in question.  For FCOR to analyze a pedigree, at least two parents and a child 
of the same family ID were required.  In some instances, only a parent and their child 
participated in the study.  817 individuals with a missing value for the trait of interest were 
created in the dataset in order to complete these families in the absence of an observed parent 
couple-child trio.  611 male (74.79%) and 140 female (17.14%) participants were created to form 
family trios.  These created individuals were not included in the above demographic information. 
Periodontal disease and dental caries can be highly influenced by the environment.  In the 
data analyses, mother-father pair-types were to account for a base line correlation that would 
occur between non-related individuals due to their environment.  Sibling-sibling pairs were used 
in the attempt to account for the many common environmental factors shared between family 
members.  Parent:offspring pairs were to represent a genetic influence and limited shared 
environmental factors.  Equal weight was given to each pair in the analysis.  In the output, the 
program indentified the number of pairs used in the analysis, which is called the count.  In some 
instances, an individual is used in more than one pair, such as a mother of three children.  FCOR 
can account for those used more than once through its weighting scheme.  FCOR provides the 
equivalence count, which is called the equiv count in the results section, reflecting the number of 
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independent pairs needed to obtain a similar standard error as that observed in the family data or 
the effective sample size. .   
3.4.2.1 Aim 1: Determine if the ability to host supragingival bacteria (S. mutans) and 
subgingival bacteria (Porphyromonas gingivalis, Treponema denticola, and Tannerella 
forsythensis (formally known as Bacteriodes forsythus)) within the supragingival and 
subgingival plaque has a genetic and/or familial component 
FCOR, a statistical program contained within S.A.G.E., was used to determine the 
presence of a family correlation in the ability to host bacteria within plaque.  Data collected 
during the dental screening exam regarding subgingival (BANA™ test) and supragingival 
(Dentocult® test) were used in the analyses.  No subgingival plaque from reference teeth were 
collected from children 6 years or younger, or from those children in which premedication was 
needed and therefore excluded from those sections of the analysis requiring those data. 
Table 5 Data used in Aim 1 analyses and eligibility based upon age 
 Age 1 – 6 years Age 7 – 10 years Age 11 – 17 
years 
Age ≥ 18 years 
Supragingival 
plaque samples 
(Dentocult®) 
YES YES YES YES 
Supragingival 
plaque sample 
from tongue 
(Dentocult®) 
YES YES YES YES 
Subgingival 
plaque samples 
from reference 
teeth (BANA™) 
NO YES if no pre-
med needed 
YES if not pre-
med needed 
YES 
Subgingival 
plaque sample 
from tongue 
(BANA™) 
YES YES YES YES 
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3.4.2.2 Aim 2: Investigate familiality in development of caries and periodontal disease 
FCOR was also used for aim 2, which was investigating a family correlation in the 
development of dental caries and periodontal disease.  Using the caries form (found in Appendix 
F), the DMFT and DMFS were calculated as indicators of dental caries development.  Probing 
depth (measured using PSR) and bleeding on probing were used as periodontal disease 
indicators. 
Some information was not available for analysis based upon the age of the study 
participant.   
Table 6 Data used in Aim 2 analyses and eligibility based upon age 
 Age 1 – 6 years Age 7 – 10 years Age 11 – 17 
years 
Age ≥ 18 years 
Edentulous YES YES YES YES 
Periodontal 
screening (PSR) 
for reference 
teeth 
NO YES if no pre-
med needed 
YES if no pre-
med needed 
YES 
Recession from 
reference teeth 
NO YES YES YES 
Bleeding upon 
probing from 
reference teeth 
NO YES YES YES 
Periodontal 
screening (PSR) 
from sextons 
NO NO NO YES 
Recession from 
sextons 
NO NO NO YES 
Bleeding upon 
probing from 
sextons 
NO NO NO YES 
Caries exam YES YES YES YES 
3.4.2.3 Explanation of variables 
The following is an explanation of the variables used throughout the data analysis. 
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Table 7 Explanation of variables used for AIM 1 
Variable Explanation 
PlaqSam1 Plaque Sample taken from the surface of intact enamel 
PlaqSam2 Plaque Sample taken from the surface of white spot lesion 
PlaqSam3 Plaque Sample taken from the surface of cavitated initial enamel lesions  
PlaqSam4 Plaque Sample taken from the excavated dentin from deep dentin lesions 
PlaqSam5 Plaque Sample taken from a tongue scraping 
TestR Tongue scraping sample taken to use for the Dentocult® SM Strip mutans test  
SupTestR# Result of the Dentocult® SM Strip mutans test on the supragingival plaque sample taken
TungRes Tongue scraping sample taken to use for the BANA-Zyme™ test  
BANA# Sample of subgingival plaque taken from tooth # for the BANA-Zyme™ test  
 
Table 8 Explanation of variables used for AIM 2 
Variable Explanation 
DMFS decayed + filled + missing tooth surfaces 
DMFT decayed + filled + missing teeth 
BL# Identification of bleeding at the site of the BANA™ sample for tooth # 
PSR# Periodontal screening and recording at the site of the BANA™ sample for tooth # 
REC# Identification of recession at the site of the BANA™ sample for tooth # 
S# PSR value for sexton # 
S#b Identification of bleeding at sexton # 
S#r Identification of recession at sexton # 
 34 
4.0  RESULTS 
The tables provided in this section are compiled of output data from the statistical program 
FCOR as described above.  FCOR is part of S.A.G.E., a statistical package used in the analysis 
of genetic and epidemiological studies.  Only those correlations found to be statistically 
significant (different from zero with p ≤ 0.05) in at least three pair-types were included in the 
tables.  Three pair-types were used to be able to best interpret the influence of environmental 
influences as compared to genetic factors.  Correlations with a standard error of > 10.0 were also 
not included in the tables due to the inability to interpret the meaning of such correlations.  
Tables including all correlations statistically different from zero are included in Appendix H.  
Table 9 and Table 10 indicate those results that were and were not statistically significant (p ≤ 
0.05) in three pair-types and those that were not. 
Table 9 Statistically significant in three pair-types versus not in three pair-types for Aim 1 
Aim 1 
Statistically Significant in three pair-types Not Statistically Significant in three pair-types
Plaque Samples 
PlaqSam2:PlaqSam2 PlaqSam1:PlaqSam1 
PlaqSam2:PlaqSam3 PlaqSam1:PlaqSam2 
PlaqSam3:PlaqSam2 PlaqSam1:PlaqSam3 
PlaqSam3:PlaqSam3 PlaqSam1:PlaqSam4 
PlaqSam4:PlaqSam4 PlaqSam1:PlaqSam5 
  PlaqSam2:PlaqSam1 
  PlaqSam2:PlaqSam4 
  PlaqSam2:PlaqSam5 
 35 
  PlaqSam3:PlaqSam1 
  PlaqSam3:PlaqSam4 
  PlaqSam3:PlaqSam5 
  PlaqSam4:PlaqSam1 
  PlaqSam4:PlaqSam2 
  PlaqSam4:PlaqSam3 
  PlaqSam4:PlaqSam5 
  PlaqSam5:PlaqSam1 
  PlaqSam5:PlaqSam2 
  PlaqSam5:PlaqSam3 
  PlaqSam5:PlaqSam4 
  PlaqSam5:PlaqSam5 
Dentocult Results 
  TestR:TestR 
  TestR:SupTestR 
  TestR:SupTestR2 
  TestR:SupTestR3 
  SupTestR:TestR 
  SupTestR:SupTestR 
  SupTestR:SupTestR2 
  SupTestR:SupTestR3 
  SupTestR:SupTestR4 
  SupTestR2:TestR 
  SupTestR2:SupTestR 
  SupTestR2:SupTestR2 
  SupTestR2:SupTestR3 
  SupTestR2:SupTestR4 
  SupTestR3:TestR 
  SupTestR3:SupTestR 
  SupTestR3:SupTestR2 
  SupTestR3:SupTestR3 
  SupTestR3:SupTestR4 
  SupTestR4:TestR 
  SupTestR4:SupTestR 
  SupTestR4:SupTestR2 
  SupTestR4:SupTestR3 
  SupTestR4:SupTestR4 
BANA Results 
Table 9 continued 
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TungRes:TungRes TungRes:Btest03 
Btest14:Btest19 TungRes:Btest14 
  TungRes:Btest19 
  TungRes:Btest30 
  Btest03:TungRes 
  Btest03:Btest03 
  Btest03:Btest14 
  Btest03:Btest19 
  Btest03:Btest30 
  Btest14:TungRes 
  Btest14:Btest03 
  Btest14:Btest14 
  Btest14:Btest30 
  Btest19:TungRes 
  Btest19:Btest03 
  Btest19:Btest14 
  Btest19:Btest19 
  Btest19:Btest30 
  Btest30:TungRes 
  Btest30:Btest03 
  Btest30:Btest14 
  Btest30:Btest19 
  Btest30:Btest30 
 
Table 10 Statistically significant in three pair-types versus not in three pair-types for Aim 2 
Aim 2 
Statistically Significant in three pair-types Not Statistically Significant in three pair-types
DMFS and DMFT measurements 
permgenDMFS:permgenDMFS permgeDMFS:permconseverDMFS 
pergenDMFS:permgenDMFT pergenDMFS:permconservDMFT 
permgenDMFT:permgenDMFS permgenDMFT:permconservDMFS 
permgenDMFT:permgenDMFT permgenDMFT:permconservDMFT 
  permconservDMFS:permgenDMFS 
  permconservDMFS:permgenDMFT 
  permconservDMFS:permconservDMFS 
  permconservDMFS:permconservDMFT 
  permconservDMFT:permgenDMFS 
Table 9 continued 
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  permconservDMFT:permgenDMFT 
  permconserveDMFT:permconservDMFS 
  permconservDMFT:permconservDMFT 
Bleeding at BANA site 
Btest03:Btest03   
Btest03:Btest14   
Btest03:Btest19   
Btest03:Btest30   
Btest14:Btest03   
Btest14:Btest14   
Btest14:Btest19   
Btest14:Btest30   
Btest19:Btest03   
Btest19:Btest14   
Btest19:Btest19   
Btest19:Btest30   
Btest30:Btest03   
Btest30:Btest14   
Btest30:Btest19   
Btest30:Btest30   
PSR at BANA site 
Btest03:Btest03   
Btest03:Btest14   
Btest03:Btest19   
Btest03:Btest30   
Btest14:Btest03   
Btest14:Btest14   
Btest14:Btest19   
Btest14:Btest30   
Btest19:Btest03   
Btest19:Btest14   
Btest19:Btest19   
Btest19:Btest30   
Btest30:Btest03   
Btest30:Btest14   
Btest30:Btest19   
Btest30:Btest30   
Recession at BANA site 
Table 10 continued 
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Btest03:Btest03   
Btest03:Btest14   
Btest03:Btest19   
Btest03:Btest30   
Btest14:Btest03   
Btest14:Btest14   
Btest14:Btest19   
Btest14:Btest30   
Btest19:Btest03   
Btest19:Btest14   
Btest19:Btest19   
Btest19:Btest30   
Btest30:Btest03   
Btest30:Btest14   
Btest30:Btest19   
Btest30:Btest30   
Sexton Bleeding results 
   S1b:S1b 
   S1b:S2b 
   S1b:S3b 
   S1b:S4b 
   S1b:S5b 
   S1b:S6b 
   S2b:S1b 
   S2b:S2b 
   S2b:S3b 
   S2b:S4b 
   S2b:S5b 
   S2b:S6b 
   S3b:S1b 
   S3b:S2b 
   S3b:S3b 
   S3b:S4b 
   S3b:S5b 
   S3b:S6b 
   S4b:S1b 
   S4b:S2b 
   S4b:S3b 
Table 10 continued 
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   S4b:S4b 
   S4b:S5b 
   S4b:S6b 
   S5b:S1b 
   S5b:S2b 
   S5b:S3b 
   S5b:S4b 
   S5b:S5b 
   S5b:S6b 
   S6b:S1b 
   S6b:S2b 
   S6b:S3b 
   S6b:S4b 
   S6b:S5b 
   S6b:S6b 
Sexton PSR results 
   S1:S1 
   S1:S2 
   S1:S3 
   S1:S4 
   S1:S5 
   S1:S6 
   S2:S1 
   S2:S2 
   S2:S3 
   S2:S4 
   S2:S5 
   S2:S6 
   S3:S1 
   S3:S2 
   S3:S3 
   S3:S4 
   S3:S5 
   S3:S6 
   S4:S1 
   S4:S2 
   S4:S3 
   S4:S4 
Table 10 continued 
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   S4:S5 
   S4:S6 
   S5:S1 
   S5:S2 
   S5:S3 
   S5:S4 
   S5:S5 
   S5:S6 
   S6:S1 
   S6:S2 
   S6:S3 
   S6:S4 
   S6:S5 
   S6:S6 
Sexton Recession results 
   S1r:S1r 
   S1r:S2r 
   S1r:S3r 
   S1r:S4r 
   S1r:S5r 
   S1r:S6r 
   S2r:S1r 
   S2r:S2r 
   S2r:S3r 
   S2r:S4r 
   S2r:S5r 
   S2r:S6r 
   S3r:S1r 
   S3r:S2r 
   S3r:S3r 
   S3r:S4r 
   S3r:S5r 
   S3r:S6r 
   S4r:S1r 
   S4r:S2r 
   S4r:S3r 
   S4r:S4r 
   S4r:S5r 
Table 10 continued 
 41 
Table 10 continued 
   S4r:S6r 
   S5r:S1r 
   S5r:S2r 
   S5r:S3r 
   S5r:S4r 
   S5r:S5r 
   S5r:S6r 
   S6r:S1r 
   S6r:S2r 
   S6r:S3r 
   S6r:S4r 
   S6r:S5r 
   S6r:S6r 
 
Mother:father pair-types were used as a base line correlation value.  They provide a 
correlation coefficient based upon no shared genetic information and limited shared 
environmental factors.  Sibling:sibling and parent:offspring pair-types were also used to consider 
genetic influences.  Parent:offspring and sibling:sibling pairs share 50% of their genetic make-
up.  However, siblings are more likely to share a greater amount of environmental influences 
than parent:offspring pairs.  Half-sibling:half-sibling pair-types were also included in the data 
analysis as a means of evaluating environmental versus genetic influences. 
Relational correlations and cross-correlations were produced throughout this analysis.  
The interpretation of the data output was the same for both types of correlations.  However, the 
results of this study focus on those correlations obtained from the same trait in two individuals.  
The table present the results of the study as trait 1 of person 1:trait 1 of person 2.  Count is the 
number of pairs that were used in the analysis while equiv. count reflects the effective sample 
size. 
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4.1 AIM 1: DETERMINE IF THE ABILITY TO HOST SUPREGINGIVAL 
BACTERIA (S. MUTANS) AND SUBGINGIVAL BACTERIA (PORPHYROMONAS 
GINGIVALIS, TREPONEMA DENTICOLA, AND TANNERELLA FORSYTHENSIS 
(FORMALLY KNOWN AS BACTERIODES FORSYTHUS)) WITHIN THE 
SUPRAGINGIVAL AND SUBGINGIVAL PLAQUE HAS A GENETIC AND/OR 
FAMILIAL COMPONENT 
Data used for the analysis of Aim 1 were those that identified a microbial species. 
Five potential plaque sample sites were identified.  All individuals, unless they were 
edentulous, had plaque samples taken from the surface of intact enamel and the tongue scraping.  
If lesions were present, a sample was taken for evaluation.   
Table 11 Significant correlation regarding plaque sample type across at least three pair-types 
  PlaqSam2:PlaqSam2 PlaqSam2:PlaqSam3 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.6 0.37 *** 370 369.4 0.20 *** 
Parent:Offspring 2054 1162.6 0.23 *** 2054 1290.1 0.07 * 
Sibling 885 489.9 0.33 *** 885 811.2 0.12 *** 
Half-Sibling             
  PlaqSam3:PlaqSam2 PlaqSam3:PlaqSam3 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.20 *** 370 369.4 0.24 *** 
Parent:Offspring 2054 1225.8 0.11 *** 2054 1392.8 0.14 *** 
Sibling 885 811.2 0.12 *** 885 585.4 0.20 *** 
Half-Sibling             
  PlaqSam4:PlaqSam4  
  count equiv count correlation    
Mother:Father 370 369.3 0.24 ***    
Parent:Offspring 2054 1304.7 0.07 **    
Sibling 885 555.6 0.24 ***    
Half-Sibling 271 192.1 0.21 **    
* 0.01 ≤ p ≤ 0.05 
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** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0255 – 0.0691 
As you can see in Table 11, plaque samples from lesions had correlations significantly 
different from zero in at least three pair-types.  It is also observed that the correlations between 
mother:father and sibling:sibling are higher than that of parent:offspring.  In addition, half-
sibling:half-sibling correlations are very similar to those of full sibling pairs.   
The Dentocult® SM Strip mutans test was used to identify the presence of mutans 
streptococci in the plaque samples taken from each participant.  The possible test results are 
negative (0) and the presence allows for a spectrum (1, 2, and 3).  The result for each sample was 
independent of the results of any other samples.  The results from this analysis did not show a 
correlation statistically significant different from zero in the pair-types in question. 
To explore the question of a familial correlation in the ability to host bacteria in 
subgingival plaque, the BANA-Zyme™ test was used.  The possible results of the microbial test 
are negative (0), weak positive (1) or positive (2).  The result for each BANA™ sample site was 
independent of the other site results.   
Table 12 Significant correlation regarding BANA™ test result across at least three pair-types 
  TungRes:TungRes Btest14:Btest19 
  count equiv count correlation count equiv count correlation 
Mother:Father 359 338.8 0.44 *** 344 312.9 0.12 * 
Parent:Offspring 1855 954.8 0.34 *** 970 414.1 0.12 * 
Sibling 776 392.7 0.39 *** 357 147.3 0.37 *** 
Half-sibling 248 148 0.28 ***       
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0286 – 0.0759 
As can be seen in Table 12, the bacteria results identified in the samples taken from the 
tongue in both individuals of the pair, and the bacteria taken from the 14th tooth of the first 
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individual and the 19th tooth of second individual were significantly correlated.  The correlations 
of the tongue results are moderately correlated and similar across all pairs other than half-
siblings, which is about half of the other pairs.  The results from the tooth sites show a larger 
correlation coefficient between sibling pairs, with the correlation values of the other pairs being 
the same.  
4.2 AIM 2: INVESTIGATE FAMILIALITY CORRELATION IN THE 
DEVELOPMENT OF CARIES AND PERIODONTAL DISEASE. 
Data used for the analysis of Aim 2 were those that measured the development of dental caries 
and periodontal disease. 
  Data used to calculate the DMFS and DMFT were taken from the dental screening 
examination form, specifically the caries exam (found in Appendix F) and input into the 
equations found in Table 8. 
Table 13 Significant correlation regarding DMFS and DMFT across at least three pair-types 
  permgenDMFS:permgenDMFS pergenDMFS:permgenDMFT 
pair-type count equiv count correlation count equiv count correlation 
Mother:Father 227 226.5 0.27 *** 228 227.4 0.23 *** 
Parent:Offspring 795 370.8 0.25 *** 795 621.3 0.32 *** 
Sibling 311 121.7 0.04 * 311 236.9 0.24 *** 
Half-sibling             
  permgenDMFT:permgenDMFS permgenDMFT:permgenDMFT 
pair-type count equiv count correlation count equiv count correlation 
Mother:Father 227 227.6 0.21 ** 228 228.1 0.16 * 
Parent:Offspring 795 355.9 0.23 *** 795 598.6 0.28 *** 
Sibling 311 236.9 0.24 *** 311 263.8 0.36 *** 
Half-sibling             
* 0.01 ≤ p ≤ 0.05 
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** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0362 – 0.0878 
Table 13 shows some correlation in pair-types regarding caries indicators.  Comparing 
DMFS:DMFS and DMFS:DMFT values, parent:offspring pairs show the highest degree of 
significant correlation.  DMFT:DMFS appears to have correlations similar to one another and 
DMFT:DMFT indicating a moderately strong sibling correlation.   
Indicators of periodontal disease, such as probing depth, bleeding upon probing, and 
recession, were used to investigate a familiality correlation in the development of periodontal 
disease.  Probing depth, bleeding upon probing, and recession were examined for each BANA™ 
sample site and sexton.   
Table 14 Significant correlation regarding bleeding at BANA™ sample sites across at least three pair-types 
  BL03:BL03 BL03:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.15 ** 370 370.1 0.16 ** 
Parent:Offspring 1082 776.3 0.15 *** 1082 767.3 0.15 *** 
Sibling 387 262.8 0.24 *** 387 271.9 0.25 *** 
Half-Sibling 93 74.7 0.26 * 93 77.9 0.25 * 
  BL03:BL19 BL03:BL30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 364.9 0.20 *** 370 368.5 0.17 *** 
Parent:Offspring 1082 809.3 0.14 *** 1082 328.7 0.16 *** 
Sibling 387 309.2 0.22 *** 387 319.9 0.20 *** 
Half-Sibling       93 90.1 0.25 * 
  BL14:BL03 BL14:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 367.8 0.18 *** 370 369.1 0.19 *** 
Parent:Offspring 1082 760.1 0.16 *** 1082 751 0.16 *** 
Sibling 387 271.9 0.25 *** 387 257.6 0.26 *** 
Half-Sibling 93 77.9 0.25 * 93 73.8 0.25 * 
  BL14:BL19 BL14:BL30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 358.9 0.26 *** 370 364.5 0.23 *** 
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Table 14 continued
Parent:Offspring 1082 791.8 0.15 *** 1082 811.1 0.17 *** 
Sibling 387 311.7 0.21 *** 387 322.7 0.19 *** 
Half-Sibling       93 91.1 0.25 * 
  BL19:BL03 BL19:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 371.9 0.15 ** 370 375 0.16 ** 
Parent:Offspring 1082 748.5 0.16 *** 1082 739 0.17 *** 
Sibling 387 309.2 0.22 *** 387 311.7 0.21 *** 
Half-Sibling             
   BL19:BL19 BL19:BL30 
   count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.22 *** 370 372.5 0.18 *** 
Parent:Offspring 1082 782.9 0.18 *** 1082 802.8 0.20 *** 
Sibling 387 275.4 0.21 *** 387 299.5 0.19 ** 
Half-Sibling             
  BL30:BL03 BL30:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.3 0.16 ** 370 372.5 0.17 *** 
Parent:Offspring 1082 758.9 0.18 *** 1082 749.4 0.18 *** 
Sibling 387 319.9 0.20 *** 387 322.7 0.19 *** 
Half-Sibling 93 90.1 0.25 * 93 91.1 0.25 * 
   BL30:BL19 BL30:BL30 
   count equiv count correlation count equiv count correlation 
Mother:Father 370 364.4 0.24 *** 370 368.9 0.20 *** 
Parent:Offspring 1082 794.6 0.19 *** 1082 814.4 022 *** 
Sibling 387 299.5 0.19 ** 387 291.2 0.17 ** 
Half-Sibling       93 79.4 0.25 * 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0342 – 0.0583 
Standard error range for half-sibling:half-sibling pair-type: 0.0993 – 0.1100 
Using bleeding at the BANA™ sample site as the trait, analyses show that all of the 
sample sites are significantly correlated with one another across at least three pair-types.  
Fourteen of the sixteen site comparisons show parent:offspring pairs as having a correlation less 
than that of the mother:father and sibling:sibling pair-types.   
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Table 15 Significant correlation regarding PSR at BANA™ sample site across at least three pair-types 
  PSR03:PSR03 PSR03:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.16 ** 370 370.8 0.17 ** 
Parent:Offspring 1082 767.2 0.16 *** 1082 779.3 0.16 *** 
Sibling 387 260.6 0.25 *** 387 268.4 0.24 *** 
Half-Sibling 93 74.4 0.26 * 93 76.3 0.24 * 
  PSR03:PSR19 PSR03:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 364.2 0.23 *** 370 366.9 0.19 *** 
Parent:Offspring 1082 794.7 0.16 *** 1082 809.9 0.15 *** 
Sibling 387 2998.2 0.23 *** 387 305.5 0.22 *** 
Half-Sibling 93 85 0.24 * 93 86.5 0.24 * 
  PSR14:PSR03 PSR14:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 367 0.20 *** 370 369.1 0.20 *** 
Parent:Offspring 1082 749.4 0.16 *** 1082 761.1 0.16 *** 
Sibling 387 268.4 0.24 *** 387 265.1 0.24 *** 
Half-Sibling 93 76.3 0.24 *    
  PSR14:PSR19 PSR14:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 363.5 0.24 *** 370 366.4 0.21 *** 
Parent:Offspring 1082 774.8 0.16 *** 1082 789.7 0.14 *** 
Sibling 387 305.5 0.23 *** 387 314.4 0.21 *** 
Half-Sibling 93 86.7 0.22 * 93 88.7 0.22 * 
  PSR19:PSR03 PSR19:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 372.6 0.17 *** 370 373.2 0.18 *** 
Parent:Offspring 1082 737.8 0.16 *** 1082 748.2 0.16 *** 
Sibling 387 2998.2 0.23 *** 387 305.5 0.23 *** 
Half-Sibling 93 85 0.24 * 93 86.7 0.22 * 
  PSR19:PSR19 PSR19:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.1 0.24 *** 370 371.1 0.21 *** 
Parent:Offspring 1082 762.9 0.18 *** 1082 778.4 0.17 *** 
Sibling 387 271.2 0.22 *** 387 288.2 0.20 *** 
Half-Sibling       
  PSR30:PSR03 PSR30:PSR14 
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  count equiv count correlation count equiv count correlation 
Mother:Father 370 370.7 0.17 ** 370 371.1 0.17 *** 
Parent:Offspring 1082 753 0.17 *** 1082 763.6 0.17 *** 
Sibling 387 305.5 0.22 *** 387 314.4 0.21 *** 
Half-Sibling 93 86.5 0.24 * 93 88.7 0.22 * 
  PSR30:PSR19 PSR30:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 366.6 0.23 *** 370 368.9 0.20 *** 
Parent:Offspring 1082 779.4 0.19 *** 1082 795 0.18 *** 
Sibling 387 288.2 0.20 *** 387 280.4 0.19 ** 
Half-Sibling       
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0343 – 0.0581 
Standard error range for half-sibling:half-sibling pair-type: 0.1019 – 0.1111 
Probing depths at the BANA™ sample site were significantly correlated across all pair-
types.  Mother:father pair-types show the largest correlation coefficient value out of the three 
pair-types.   
Table 16 Significant correlation regarding recession at BANA™ sample site across at least three pair-types 
  REC03:REC03 REC03:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.16 ** 370 370.9 0.17 ** 
Parent:Offspring 1082 753.4 0.16 *** 1082 766.5 0.19 *** 
Sibling 387 250.7 0.28 *** 387 260.8 0.27 *** 
Half-Sibling 93 72.5 0.26 * 93 75.2 0.26 * 
  REC03:REC19 REC03:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 365.1 0.22 *** 370 368.4 0.18 *** 
Parent:Offspring 1082 794.4 0.15 *** 1082 810.9 0.15 *** 
Sibling 387 290.4 0.26 *** 387 300.4 0.24 *** 
Half-Sibling       93 85.8 0.24 * 
  REC14:REC03 REC14:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 366.8 0.20 *** 370 369.1 0.20 *** 
Parent:Offspring 1082 736.8 0.16 *** 1082 749.9 0.17 *** 
Sibling 387 260.8 0.27 *** 387 257.1 0.26 *** 
Table 15 continued
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Table 16 continued 
Half-Sibling 93 75.2 0.26 * 93 73.7 0.26 * 
  REC14:REC19 REC14:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 361 0.26 *** 370 365.6 0.22 *** 
Parent:Offspring 1082 777 0.15 *** 1082 793.4 0.16 *** 
Sibling 387 297.8 0.25 *** 387 309.5 0.23 *** 
Half-Sibling       93 88.1 0.24 * 
  REC19:REC03 REC19:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 372.1 0.17 *** 370 374.5 0.18 *** 
Parent:Offspring 1082 722.6 0.16 *** 1082 735.3 0.18 *** 
Sibling 387 290.4 0.26 *** 387 297.8 0.25 *** 
Half-Sibling             
  REC19:REC19 REC19:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.1 0.23 *** 370 371.8 0.19 *** 
Parent:Offspring 1082 764.4 0.17 *** 1082 780.7 0.18 *** 
Sibling 387 267.1 0.23 *** 387 285 0.21 *** 
Half-Sibling             
  REC30:REC03 REC30:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.5 0.17 *** 370 371.8 0.18 *** 
Parent:Offspring 1082 740 0.17 *** 1082 753 0.19 *** 
Sibling 387 300.4 0.24 *** 387 309.5 0.23 *** 
Half-Sibling 93 85.8 0.24 * 93 88.1 0.24 * 
  REC30:REC19 REC30:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 365.5 0.23 *** 370 368.9 0.19 *** 
Parent:Offspring 1082 782.6 0.18 *** 1082 799.3 0.19 *** 
Sibling 387 285 0.21 *** 387 278.7 0.20 *** 
Half-Sibling             
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0343 – 0.0583 
Standard error range for half-sibling:half-sibling pair-type: 0.1013 – 0.1107 
Recession was found to be least correlated between parent:offspring pairs as compared to 
mother:father and sibling:sibling.  In many cases, the sibling:sibling pair-type showed the highest 
significant correlation and was similar to the value for half-sibling pairs.   
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No significant correlations were identified regarding the PSR, bleeding, and recession 
results for the sextons of the mouth across at least three pair-types.  In the case of sibling:sibling 
and parent:offspring pair-types, there too few individuals who had data from this procedure.  
Even among the mother:father pair-types, no significant correlations were observed. 
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5.0  DISCUSSION 
This is one of a small number of studies conducted to assess familial correlations for the ability 
to host specific bacteria in plaque and the development of dental caries and periodontal disease.  
The presence of certain oral bacteria has been associated with an increased risk of cardiovascular 
disease, suggesting that those at a higher risk to host these specific bacteria may be more likely 
to develop cardiovascular disease.  If there is a familial correlation regarding the presence of 
these bacteria in the mouth, it may suggest a need to improve our standard of care for those 
individuals who are predisposed to dental caries, periodontal disease and hosting those bacteria 
associated with those diseases.  The purpose of this study was to 1) identify a familial correlation 
in the ability to host such bacteria and 2) identify a familial correlation in the development of 
dental caries and periodontal disease.  The third purpose of this study was dependent upon the 
results of the first two aims.  The third purpose was to suggest a revision to our dental health 
standard of care in the presence of familiality of the trait in question.   
In general, these study results suggest that the influences of both an individual’s 
environment and genetic make-up are involved in a complex manner in the ability to host 
specific bacteria in plaque and develop the oral conditions in question.  For all of the variables 
analyzed, the correlations of all the relative pair-types were relatively similar and may overlap 
when considering the standard of error.  This may suggest an importance of both environmental 
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and genetic factors, the inability of the statistical test used to accurately evaluate the features in 
question, and/or the influence of factors that were not considered in this study. 
5.1 DISCUSSION OF RESULTS REGARDING AIM 1: DETERMINE IF THE 
ABILITY TO HOST SUPRAGINGIVAL BACTERIA (S. MUTANS) AND 
SUBGINGIVAL BACTERIA (PORPHYROMONAS GINGIVALIS, TREPONEMA 
DENTICOLA, AND TANNERELLA FORSYTHENSIS (FORMALLY KNOWN AS 
BACTERIODES FORSYTHUS)) WITHIN ORAL PLAQUE HAS A GENETIC AND/OR 
FAMILIAL COMPONENT 
5.1.1 Supragingival plaque  
Two different factors were investigated in this subsection of aim 1) presence of disease, 
and 2) presence of bacteria.  The results of these different situations may have different 
implications.   
The presence of disease appears to be under stronger environmental influence as 
compared to a genetic influence.  This is supported in that mother:father pairs had larger 
correlation values when compared to parent:offspring.  In addition, mother:father pairs had 
higher correlations than sibling:sibling pairs with the exception of samples taken from deep 
dentin lesion compared with itself and compared with tongue scraping.  Since it is assumed that 
mother:father pairs share no genetic information, this is even greater support of environmental 
factors influencing the development of dental lesions, which many times lead to dental caries.   
In many cases, the correlation values of full sibling pairs and half-sibling pairs were very similar, 
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evidence that the dental traits may be explained by a small genetic component.  Comparisons 
mentioned here were restricted to correlations which reached statistical significance.  The 
implications of this are discussed further below. 
The presence of S. mutans in supragingival plaque did not result in any correlations 
significantly different from zero across at least three relative pair-types.  Many of the pair-type 
correlations used only a small number of pairs for analysis.  This may have resulted in an 
inaccurate correlation.  In addition, the small number of pairs that were available for analysis 
resulted in standard errors greater than or equal to 10.0.  Given the variability in the correlation 
value due to the standard error, it was inappropriate to include these statistically significant 
correlations in the analysis compared with other pair-types.  It is possible that these results 
suggest that the presence of mutans streptococci is uncorrelated among those with shared genetic 
information and those who share an environment.  However, these results are unreliable given 
the small number of pairs included in the analysis. 
5.1.2 Subgingival plaque 
The BANA™ test identifies the presences of three anaerobic bacteria, Porphyromonas 
gingivalis, Treponema denticola, and Tannerella forsythensis (formally known as Bacteriodes 
forsythus) 31.  Many of the results pertaining to bacteria identified in the BANA™ test were not 
significantly correlated across at least three pair-types.  Plaque collected from the tongue of both 
individuals in the pair showed similar correlations for all pair-types.  Given these results, it is 
unclear that there is a genetic component to this feature.  Plaque collected from tooth 14 and 19 
showed higher correlation for the sibling:sibling pair-type.  This may be evidence of the trait 
being influenced by genetic make-up.  However, this cannot be said for certain since siblings 
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also share environmental factors.  It is possible that environmental and genetic factors play a role 
in the presence of subgingival bacteria since the sibling pair correlation is greater than 
mother:father pair-type, which should be greater if environmental factors were the only crucial 
component.   
5.1.2.1 Confounding factors and limitations specific to determining a familial correlation in 
the ability to host specific bacteria in subgingival plaque 
The age of the participants determined the type of samples that could be taken.  Children 
under the age of 6 years old did not participate in the subgingival plaque collection for the 
BANA™ test.  Therefore, these results may not be applicable to young children and their parents 
in regards to the ability to host subgingival plaque. 
The BANA™ test does not differentiate between P. gingivalis, B. forsythus, and 
Treponema denticola 31.  This study looked only at the degree in which bacteria was present in 
the mouth.  It does not account for additional subgingival bacteria that may be in the mouth.  The 
test also does not differentiate relative amounts of the different types of bacteria, which may 
influence the risk to develop cardiovascular disease. 
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5.2 DISCUSSION OF RESULTS REGARDING AIM 2: INVESTIGATE 
FAMILIALITY IN THE DEVELOPMENT OF CARIES AND PERIODONTAL 
DISEASE 
5.2.1 Dental caries 
DMFS and DMFT values have been used as a method to indicate and quantify the extent 
of dental caries.  As indicated in Table 8, DMFS considers the tooth surfaces and quantifies the 
number decayed, missing and filled.  DMFT considers the whole tooth and quantifies the number 
decayed, missing and filled.  These values were then used to calculate the correlation.   
Two different equations were used for DMFS and DMFT.  A conservative value was 
calculated, which was stricter and more exclusive regarding the definition of decayed, missing 
and filled.  The nonconservative value had a broader and more inclusive definition of decayed, 
missing, and filled.  None of the conservative correlations were found to be statistically 
significant across three or more pair-types.   
Primary and permanent teeth were also evaluated.  Many of the adults in the study were 
not given a primary DMFS or DMFT due to not having primary teeth remaining in the mouth.  
Therefore, DMFS and DMFT values for permanent teeth only were used in the analysis.   
DMFS values of parents compared to their offspring showed a larger correlation 
coefficient than among the parent pairs and sibling pairs.  This is evidence that genetic factors 
may influence decay, loss, or need to fill teeth.  Given that parents and their children are still 
likely to share some of the environmental influences, the impact of the environment cannot be 
ruled out.   
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Parent DMFT values compared with their offspring did not show the same result and was 
found to have values in between the other groups.  Sibling pair DMFT values showed the highest 
significant correlation.  However, given the range of the standard error, these values are likely to 
overlap, complicating the interpretation of the results. 
5.2.1.1 Confounding factors and limitations specific to investigating the familiality of the 
development of dental caries 
There is evidence that the development of dental caries has many stages of disease 10.  
These include white spot lesions, cavitated enamel, and repaired dentin.  White spots are not 
always observable and may only be detected with the use of an x-ray 10.  In the study, only a 
visual caries exam was performed, therefore, it is possible that some early signs of dental caries 
may have not been identified.   
Tooth structure and shape has been shown to influence the ability to remove plaque on 
the tooth surface 10.  These features were not considered in the data that was collected for each 
participant.  Therefore, it is possible that these features may have confounded the results. 
DMFT and DMFS calculation do not consider early event evidence of dental decay, such 
as the white spot 5.  DMF does not include the variability of expression of these conditions 10.  
DMFS may also be subject to over-treatment effects.  Unnecessary fillings may have been 
performed as a preventative or over-cautious measurement.  During the dental screening 
examination, necessary and unnecessary dental caries fillings were indistinguishable.   
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5.2.2 Periodontal disease 
Probing depth (PSR), bleeding upon probing, and recession have been identified as predictors of 
periodontal disease and were used in this study as such.  These measurements were evaluated for 
each site in which a sample was taken for the BANA™ test as well as the value for each sexton 
of the mouth.   
The results from the sites in which a sample for the BANA™ test were taken showed a 
significant correlation across at least three pair-types for each site comparison.  The results of the 
sexton measurements did not show significant correlation across at least three pair-types in any 
of the comparisons.  This was likely due to the small number of pairs available for results as well 
as the lack of significant correlations between parent:offspring pair-types.  Therefore, only the 
results from the BANA™ comparisons will be used. 
All of the site comparisons, with the exception of two sites measures for bleeding upon 
probing, resulted in the parent:offspring pair-type having the lowest correlation coefficient value.  
The correlation coefficients in the majority of comparisons were similar and may overlap when 
considering the standard error.  In addition, many cases in which the half-sibling:half-sibling 
pairs show a significant correlation coefficient, the value was similar to that of the sibling:sibling 
pair-types.   
5.2.2.1 Confounding factors and limitations specific to the investigation of the familiality of 
the development of periodontal disease 
Participants under the age of 6 did not have any sample taken for BANA™ or 
measurements for PSR, bleeding upon probing or recession.  Those participants between the ages 
of 7 and 17 years old did not have sexton measurements taken but fully participated in the 
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BANA™ procedure, including PSR, bleeding upon probing, and recession measurements.  This 
may influence the lack of data for the sextons and be the cause of the low number of pairs.  Also, 
this limits the detection of the beginning stages of periodontal disease which may be evident 
under 6 years of age. 
Cigarette smoking has been shown to be as important as microbiological factors in 
determining periodontal severity 14.  Environmental factors, such as smoking, were not 
accounted for in the analysis of the data.  It is possible that correlations may change when these 
factors are considered.   
Periodontal disease has a variable expression.  Measuring the presence or severity by 
deep pockets does not encompass the variability in the disease expressivity 10.  Bleeding upon 
probing and recession were also considered as features of periodontitis in this study.  There are 
other characteristics of periodontal disease they may not have been identified. 
5.3 DISCUSSION OF CONFOUNDING FACTORS AND LIMITATIONS 
In the process of this study, many confounding factors and limitations became apparent.  Most 
importantly, oral hygiene of each study participant was not taken in to account.  Many studies 
have shown that brushing and flossing can reduce the amount of plaque detected on the surface 
of the tooth, as well as those bacteria near the gum line 8.  The addition of mouth wash can 
further reduce the amount of bacteria in the mouth.  The oral hygiene status of the participant 
may be an important factor in determining disease risk.  Pair-types were used as a method to 
tease out environmental factors (mother:father and sibling:sibling) versus genetic factors 
(parent:offspring) that play a role in hosting bacteria and oral disease.  Information on the oral 
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health habits of each participant may be important since a mother and father may not have 
similar health habits.  This would allow for one important variable to be controlled.   
Specific environmental factors may play a role in disease development, such as 
socioeconomic status and access to health care.  These factors may limit the access to oral health 
educational services and material, as well as dental care that has been shown to be beneficial in 
the reduction of plaque and maintenance of oral health.  Certain types of medication and 
cigarette smoking have been shown to influence the development of dental disease 14.  Cigarette 
smoking has been shown to be as important as microbiological factors in periodontal severity.  
Diet and stress also play a role in the amount and type of bacteria found in the mouth as well as 
dental cavities and periodontal disease. Data regarding these potential factors were collected 
through the study but were not considered in the data analysis.   
The definition regarding environment between individuals was restrictive and perhaps 
outdated.  Generational proximity was the prominent characteristic in determining amount of 
shared environment between pairs.  During this study, it was assumed that siblings shared the 
greatest amount of environmental factors and parents shared the least.  The individual’s age, 
relationship and interaction with different family members, and living situation may influence 
the amount of environmental factors shared between pair-types.  Accounting for these 
uncertainties is complicated by the unique relationship and interaction of each family and the 
members of that family.  In addition, shared individual-level environmental factors also need to 
be considered.  Such shared factors may include the number of bathrooms in the home, affecting 
the amount of shared time and exposures in that area, as well as dietary habits, which influence 
the types of food to which an individual may be exposed,   
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The age of the participant was a large confounding factor in this study.  Age determined 
the type of samples that could be obtained and procedures that could be performed.  This may 
have influenced the results of the data due to samples or measurements that could not be 
collected.  It is possible also that some of the data analyzed may have different results for the 
same individual dependent upon their age.  Periodontal disease is seen more commonly in 
individuals over the age of 65 13 but it unclear as to if it is due solely to environmental influences 
or if their genetic make-up played a role as well.  Siblings are also more likely to share many 
environmental factors with one another if they are of similar age.  The large amount of shared 
environmental factors may create noise in the data and complicate interpretation.  There may be 
so many similar environmental factors that they negate the role of genetic make-up that may be 
detected.  Age also may affect the opportunity for more shared environmental factors.  Parent 
couples have most likely spent more time in a shared environment than sibling pairs.  Sibling 
pairs have a shared environment for only as long as the age of the youngest child.  Therefore, it 
is possible that parent pairs have spent more time in a similar environment and that the oldest 
child has shared more environmental factors with their parents than their youngest sibling. 
An additional factor that was noted through the analysis of the COHRA data was that 
more females were involved in the study than males.  The demographics of this population 
appeared to be fairly balanced between males and females; however, many of the males in the 
study were children of female participants.  Due to this bias, more data was collected on females 
and their children as compared to males and their children.   
It is possible that the results may be biased due to the inclusionary criteria for the data 
analysis.  Only those correlations that were statistically significant were included in the analysis.  
Due to this criterion, it is important to cautiously interpret the current study’s findings because 
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correlations encompassing zero through lack of statistical significance were not included for 
consideration here.  A correlation of zero or non-significant correlation would indicate that there 
is no evidence of a non-zero correlation and would be an important result. 
 
5.4 CONCLUSION 
The results of this study suggest that environmental factors play a role in the ability to host 
supragingival and subgingival bacteria, as well the development of dental caries and periodontal 
disease.  The degrees to which genetic factors are involved is still unclear based on the results of 
this study alone.  This has made the need for additional studies more apparent.   
5.4.1 Aim 3: If the family correlations are consistent with a significant genetic component, 
investigate possible modifications to current dental health recommendations 
The results of this study do not support the need to adjust the current oral health standard of care 
at this time.  The influences of the environment and an individual’s genetic make-up appear to be 
complex.  More evidence and understanding through clinical and scientific studies are necessary 
if changes are to be recommended.  
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5.4.2 Implication for public health and clinical care 
The link between cardiovascular disease and oral health continues to be supported through 
clinical studies and research.  As the knowledge regarding the relationship between the diseases 
become more defined, efforts will be put forth to determine how to lower the risk of 
cardiovascular disease through oral health.  If the role of environment and genetic factors can be 
clarified, individuals at risk for these diseases may be identified and preventative and risk 
reduction interventions can be applied. 
Further investigation into the influences of dental caries and periodontal disease is 
necessary to determine how to best treat patients.  The need is no longer simply for good oral 
health, but overall health, especially cardiovascular.  As the relationships and influences of these 
conditions become clearer, clinical care can adapt to incorporate the new information and treat 
patients in the best way possible. 
5.4.3 Implications for future studies 
More studies are necessary to further define the association between cardiovascular disease and 
oral health.  Knowing the relationship between these conditions will allow us to determine if 
dental caries and periodontal disease may be a marker for risk or a causal factor 16.  Should these 
oral health conditions be found to be as causal factors, their prevention and management may 
lead to a decrease in the development of other serious systemic diseases, such as cardiovascular 
disease 5.   
Humphrey et al. suggested that longitudinal studies beginning in childhood and 
randomized controlled trials (acknowledging the ethical issues) be conducted.  In any study that 
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is carried out, standardized definitions and measurements of dental caries, periodontal disease, 
and cardiovascular disease will need to be determined and should include careful and consistent 
follow-up 16. 
The identification of genetic risk factors (via linkage) in combination with environmental 
factors and microbial make up may allow for at-risk individuals to be identified, pre-
symptomatic treatment, or avoidance of certain behaviors (i.e. smoking) 14.   
Studies accounting for confounding factors and limitations in this study should be 
performed.  An understanding of factors such as age, cigarette smoking, and oral hygiene 
behaviors, may provide clarification of the different roles that genetic and environmental factors 
play in oral health. 
The results from this study should be reinterpreted with all those values without a 
significant p-value.  Important information may have been lost due to the inclusionary criteria for 
the data analysis. 
Further studies in the relationship between oral health, environmental factors and genetic 
make-up are necessary to determine the best plan of treatment.  This knowledge may be able to 
assist in offering prophylactic care to children who are at high risk of developing dental caries or 
periodontal disease.  Reducing the incidence of oral health disease may help to reduce the 
incidence of cardiovascular disease and other health concerns. 
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APPENDIX A 
STUDY PARTICIPANT CONSENT FORM FOR PENNSYLVANIA SITES 
CONSENT TO BE A SUBJECT IN A RESEARCH STUDY  
 
TITLE:  Genetic Factors Contributing to Oral Health Disparities in Appalachia 
(Pennsylvania Sites) 
 
PRINCIPAL  Mary L. Marazita, Ph.D., F.A.C.M.G. 
INVESTIGATOR: Professor, Oral/Maxillofacial Surgery; Assoc. Dean of Research 
School of Dental Medicine, University of Pittsburgh 
Suite 500 Cellomics Building/100 Technology Drive 
Pittsburgh,  PA   15219       USA 
Telephone:   412-648-8380  
 
CO-   Robert J. Weyant, D.M.D., Ph.D. 
INVESTIGATORS: Head, Division of Pediatric and Developmental Dental Sciences 
School of Dental Medicine, University of Pittsburgh  
Pittsburgh, PA   15261        
Telephone:  412-648-3076 
 
Katherine Neiswanger, Ph.D.  
Ph.D. Medical Geneticist 
School of Dental Medicine, University of Pittsburgh 
Suite 500 Cellomics Building, 100 Technology Drive 
Pittsburgh, PA   15219       USA 
Telephone:  412-648-8384 
  
 
Louise Platt-Schulhof, RDH, MHPE, CHES 
UPMC Braddock 
400 Holland Avenue 
Braddock, PA  15104 
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Telephone: 412-636-5276 
 
SOURCE OF SUPPORT: National Institute of Dental and Craniofacial Research, U.S.A. 
 
Why is this research being done? 
 
Dr. Marazita and Dr. Weyant invite you to be in a study to learn more about dental health in 
families, including behaviors, genes (those factors that determine a person’s physical 
characteristics and have been passed to them from their parents), and periodontal (gum tissue) 
factors.  Oral health varies greatly among different people.  The purpose of this study is to 
identify which genes, attitudes, and behaviors play a role in people’s oral health, so that risk 
factors for oral health problems can be better understood. 
 
Who is being asked to take part in this research study?  
 
You are a member of one of approximately 700 families from West Virginia or Western 
Pennsylvania with at least one child between 1 and 18 years old, who is being asked to 
participate in this study.  Your family is part of a representative sample of similar families in 
Braddock, Pennsylvania. 
 
What procedures are being performed for research purposes? 
 
You and your family will be asked to participate in a 4-part examination process during this visit.  
You and your family will also be asked to return every two years, for a total of three or four 
visits over five to seven years.  If you agree to participate, you will undergo the following 
procedures during this visit. You have the right to participate in only one, two, three, or all four 
parts of the examination: 
 
Part 1)  Questionnaires:  You will be asked a series of questions about your behaviors, 
thoughts, and opinions regarding dental health, general health, prevention, family relationships, 
parenting practices, social relationships, alcohol, drug and tobacco use, and mental health (for 
example, self esteem and mental illness).  Demographic information (for example, age) and 
general health history (for example, vaccinations and frequency of check ups) also will be 
recorded.  In addition, you will be asked to complete questionnaires that focus on medical 
symptoms, dental anxiety, and social history.  You will be given an opportunity to examine these 
questionnaires and do not have to answer all the questions. This part of the study will take about 
2 hours.   
Part 2) Dental, Microbiological and Tobacco Examinations:  You will be given a dental 
screening to document the presence of oral conditions, including dental decay (cavities), gum 
infections (called gingivitis and periodontitis by dentists), tooth alignment and crowding, dental 
or oral injury, and a variety of other conditions of the teeth and mouth (for example, thin 
enamel).  The dental exam will be conducted by a licensed dentist or dental hygienist and is 
similar to a routine checkup visit to a family dentist, except no x-rays will be taken.  During this 
exam, you will be asked questions regarding your dental status, such as history of tooth injury, 
and brushing and flossing habits. All people have different kinds of bacteria present in their 
mouth, so the purpose of the oral microbiological exam is to test your saliva (“spit”) and the 
plaque on your teeth for bacteria that could cause cavities or gum infections.  For this 
examination, you will provide a saliva sample by chewing on a wax pellet and then spitting into 
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a vial.  You will have a test to check the flow of your saliva.  Your saliva will also be used to 
check if there is any evidence of tobacco use.  A plastic strip will be placed on your tongue to 
collect saliva.  The inside of your cheek may also be scraped to collect a sample.  Dental 
instruments and special toothpicks will be used to scrape and collect dental plaque from your 
teeth and tongue.  A long Q-tip will be used to collect a throat swab from the back of your throat.   
If any dental problems are found, you will be given referral information and can seek dental care 
at your own expense.  Dental care will not be provided as part of this study. This part of the 
study will take about 1 hour. 
Part 3)   Blood sample for DNA studies:  Approximately one and one half teaspoons blood will 
be used to evaluate your DNA for genes relating to dental health, such as those which affect 
cavities, tooth development, or wound healing.  If you are unwilling to give a blood sample, you 
will be provided some mouthwash and the rinse will be collected, or the inside of your cheek will 
be swabbed with several brushes to collect cells that contain DNA.  If you are unwilling to give a 
blood sample, you have the option of providing a saliva (spit) sample or having the inside of 
your cheek swabbed with several cotton swabs to collect cells that contain DNA.  If necessary, 
you could also be provided some mouthwash to rinse to collect the DNA.  This part of the study 
will take 5 minutes or less, and will only be done at one visit, unless the sample is insufficient to 
complete the study. 
Part 4) Water Sampling:  You have been sent a vial to collect a sample of your drinking water 
from your home.  This water will be tested for fluoride, a mineral in some people’s water that 
can prevent cavities.  Please bring this vial with you to your appointment.   
 
What are the possible risks, side effects, and discomforts of participating in this research 
study? 
 
1)  The questions in the interviews and questionnaires may be personal.  If any information about 
child abuse, neglect, or mistreatment is uncovered, then the law requires that it be reported.  
2)  The dental screening infrequently causes some slight gum bleeding, which usually stops 
within a few minutes. If you have a serious gum infection, you may be sensitive to the gum 
examination. There is a rare risk that probing your gums may cause an abscess, or infection, of 
the gum tissue. Although this is rare and usually goes away within a short period of time, it 
might be painful and require treatment with antibiotics.  
3) The gum examination is usually not a risky procedure for most healthy people.  But, if you 
have had previous bacterial (infective) endocarditis, certain specific and serious congenital 
(present from birth) heart conditions, or artificial heart valves or have had a knee or hip replaced, 
this examination could place you at risk for a bacterial infection that would affect your heart and 
the joints in your bones. You will be asked if you have ever had any of these heart or joint 
problems, and if so, you will be asked to obtain and take an antibiotic (either amoxicillin or 
clindamycin, azithromycin, or clarithromycin) at your own expense an hour before the gum 
examination. 
If you have the reduced ability to resist infection, this examination could place you at risk for 
developing an infection.  If you have the reduced ability to form blood clots, you could be at risk 
for mild, but prolonged bleeding during some of the exam procedures.  Prior to the dental exam, 
you will be asked in detail about having either of these conditions.  If you have a reduced ability 
to resist infection or form blood clots, you will be excused from all parts of the examination that 
might cause bleeding.  
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4)  Collection of tooth plaque, as well as the tongue and cheek scrapings, is likely to be briefly 
uncomfortable. The throat swab will likely lead to a brief gagging response.  
5)  The needle puncture of your vein to obtain the blood sample may infrequently result in pain 
and soreness, bruising, fainting, and rarely infection.  This procedure will be performed by 
individuals trained and experienced in obtaining blood samples so as to minimize these risks. 
6)  In the unlikely event of a breach of confidentiality, there is a very remote possibility that the 
genetic information could affect your ability to be insured, employed, or your family 
relationships.  Such problems are probably rare.  You can ask the investigators about the 
likelihood of the research discovering anything that would lead to these problems.  
 
What are the possible benefits of participating in this research study? 
 
By participating, you may learn more about your own dental and overall health.  You will 
receive verbal and written feedback about your dental screening.  If your dental screening any 
significant problems, you will also receive names of some dentists or other health professionals 
who could help with any related dental/medical needs.   The information obtained from your 
participation in this research study may eventually lead to a better understanding and better 
treatments for oral health problems. 
 
If I agree to take part in this research study, will I be told of any new risks that may be found 
during the course of this study? 
 
You will be promptly notified if any new information develops during the conduct of this 
research study, which may cause you to change your mind about continuing to participate. 
 
Will I or my insurance company be charged for the cost of any procedures performed as part 
of this research study? 
 
None of the services and/or procedures (Dental Screening, blood draws, etc.) you receive during 
this research study will be billed to you or your health insurance.  If you get a bill or believe your 
health insurance has been billed for something that is part of the study, notify a member of the 
research team or UPMC Patient Billing Services.    
 
You and your health insurance will be charged, in the standard manner, for services and 
procedures provided for your routine care.  If you are required to take the prophylactic oral 
antibiotic prior to a dental exam, either you or your insurance company will be charged the cost 
of obtaining the antibiotic.  The study will reimburse you for any out-of-pocket costs for the 
prophylactic antibiotic. 
 
Will I be paid if I take part in this research study? 
 
You will be paid $5.00 for each procedure of the study that you complete, with an added $5.00 if 
all four procedures are completed, up to $25.00 for one visit.  Payment will be in the form of a 
gift card to your choice of Giant Eagle, Target, or Wal-Mart.  Each time you return for the study 
(every 2 years for a total of 3 or 4 visits), you will be paid these same amounts.  Over a 5 – 7 
year period, you could potentially receive $75 - $100 dollars worth of gift cards depending on 
the total number of visits.  You will also be reimbursed for any out-of-pocket expenses, 
including long distance communication, transportation, parking, one meal, and any costs of 
obtaining a blood sample at a local lab. 
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Who will pay if I am injured as a result of taking part in this study? 
 
University of Pittsburgh researchers recognize the importance of your voluntary participation in 
their research studies.  These individuals and their staffs will make reasonable efforts to 
minimize, control, and treat any injuries that may arise as a result of this research.  If you believe 
that you are injured as a result of the research procedures being performed, please contact 
immediately the Principal Investigator listed on the first page of this form. 
Emergency medical treatment of injuries solely and directly related to your participation in this 
research study will be provided to you by the hospitals of UPMC.  It is possible that UPMC may 
bill your insurance provider for the costs of this emergency treatment, but none of these costs 
will be charged directly to you.  If your research-related injury requires medical care beyond this 
emergency, you will be responsible for the costs of this follow-up care unless otherwise 
specifically stated.  There is no plan for monetary compensation. You do not, however, waive 
any legal rights by signing this form. 
 
Who will know about my participation in this research study? 
 
Any information obtained about you from this research study will be kept as confidential as 
possible. All information about you or your involvement in this research study will only be 
accessible to the investigators involved in this study and their research staff, and will not be 
released to anyone without your written permission.  Records and information pertaining to your 
identity and involvement in this research study will be stored in locked file cabinets at the 
[School of Dentistry of the University of Pittsburgh or at UPMC Braddock. Computer records 
will be kept in password protected, secured databases.  Your identity on data records, donated 
blood and dental samples, and DNA will be indicated only by code number. Records linking the 
codes to your personal identifying information will be stored in a separate, secure location.  You 
will not be identified by name in any publication of the research results unless you sign a 
separate form giving your permission. 
 
Will this research study involve the use or disclosure of my identifiable medical information? 
 
This research study will NOT involve the use or disclosure of your identifiable medical 
information from your hospital or physician records, or future medical information that might 
become available during your participation in this study.  This study will record some of your 
personal health or medical information, which will be kept separate from your medical records, 
and used only for research purposes. 
 
Who will have access to identifiable information related to my participation in this research 
study? 
 
The information learned about you during this study will not be released to anyone (for example, 
relatives, personal physicians, insurance companies, or any other third party) without your prior 
written permission.   However, in the unlikely event that an interviewer identifies someone who 
is considered to be at immediate risk for harming him or herself or others, they will need to 
inform the appropriate agencies, as required by Pennsylvania law.  Any information about child 
abuse, neglect, or mistreatment must also be reported.  These research records, just like hospital 
records, may be subpoenaed by court order or may be inspected by federal regulatory authorities.   
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In addition to the investigators listed on the first page of this consent form and their research 
staff, the following individuals may have access to identifiable information related to your 
participation in this research study.  Authorized representatives of the University of Pittsburgh 
Research Conduct and Compliance Office may review your identifiable research information 
for the purpose of monitoring the appropriate conduct of this research study.  In addition, 
authorized representatives of the University of Pittsburgh may have access to this information 
for the purpose of making participant payments.  
 
For how long will the investigators be permitted to use identifiable information related to my 
participation in this research study? 
 
The investigators may continue to use identifiable information related to your participation in 
this research study for at least 5 years following the completion of the research study. 
 
May I have access to my personal research information resulting from my participation in this 
research study? 
 
You will be notified if you have any dental problems.  You will not be provided with your 
personal research or genetic information obtained during this study.    
 
Is my participation in this study voluntary? 
 
Your participation in this research study is completely voluntary.  Whether or not you provide 
your consent for participation in this research study will have no effect on your current or future 
medical care at a UPMC Hospital or affiliated health care provider, or your current or future 
relationship with a health care insurance provider or with the University of Pittsburgh.  If you 
turn 18 during the course of the study, your parent’s permission is no longer valid, and you will 
be re-contacted to give permission as an adult. 
   
May I withdraw, at a future date, my consent for participation in this research study? 
 
You do not have to take part in this study and, should you change your mind, you can withdraw 
from the study at any time by submitting a dated, written request to withdraw to Dr. Marazita, 
who is listed on page 1 of this form.  Any research information recorded before your withdrawal 
may continue to be used in the research study.  Your decision to withdraw from this research 
study will have no effect on your current or future medical care at a UPMC Hospital or affiliated 
health care provider, or your current or future relationship with a health care insurance provider 
or with the University of Pittsburgh.  You may be removed from the study by the investigators, if 
the information you provide is incorrect.  If you withdraw or are removed from this research 
study, your biological samples, blood sample, and DNA will be destroyed.    
 
Will my DNA samples be used for future studies? 
 
Dr. Marazita will control the use of your biological samples and genetic material for this study, 
and will store your biological samples with codes in freezers at the University of Pittsburgh and 
West Virginia University.  In the future, new research may identify other factors that could be 
involved in oral health.  If this happens, Dr. Marazita would also like to examine them.  Thus, if 
you agree, your biological samples and DNA will be saved for future testing of newly identified 
factors involved in oral health.  When all of her research studies of oral health are completed, 
any remaining biological samples and DNA will be destroyed at that time.  If you do NOT agree, 
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your biological samples and DNA will be discarded at the end of this particular research study.  
You may also be contacted in the future to be invited to participate in additional research, but 
that future involvement is voluntary as well.  If you turn 18 during the course of the study, your 
parent’s permission is no longer valid, and you will be re-contacted to give permission as an 
adult regarding the use of your DNA samples.  
Your blood sample and its DNA used in this research study may contribute to a new invention or 
discovery.  Sometimes, these inventions or discoveries may be of commercial value and may be 
sold, patented, or licensed by the investigators and the University of Pittsburgh for use in other 
research or the development of new products related to oral health.  If the research investigators 
are able to develop new products from the use of your biological sample or genetic material, they 
currently have no plans to share any money or other rewards with you.  You retain the right to 
have your blood sample and its DNA destroyed if you decide to withdraw from this research 
study. 
************************************************************************
******************************************************************************
****** 
I give my permission for Dr. Marazita to save my biological samples and genetic material, 
with personal identifiers, for use in other genetic research projects involving the study of 
oral health. 
 
   YES ______    NO ________ 
 
I give my permission to be re-contacted to obtain my consent if there is a desire to use my 
biological sample or genetic material, with personal identifiers, in other research projects 
involving the study of different diseases or conditions. 
 
   YES ______    NO ________ 
 
 
 
VOLUNTARY CONSENT AND AUTHORIZATION 
 
All of the above has been explained to me and all of my current questions have been answered.  I 
understand that I am encouraged to ask additional questions at any time about this research 
study, and that such future questions will be answered by the researchers listed on the first page 
of this form.  Any questions I have about my rights as a research participant will be answered by 
the Human Subject Protection Advocate of the IRB Office, University of Pittsburgh (1-866-212-
2668).   
 
By signing this form, I agree to participate in this research study. A copy of this consent form 
will be given to me. 
 
 
Adults aged 18 and over: 
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____________________________________ ________________________ 
Participant’s Signature    Date 
 
       
Children aged 1 – 17: 
 
I understand that, as a minor (age less than 18 years), 
_____________________________________ is not permitted to participate in this research 
study without my consent.  Therefore, by signing this form, I give my consent for their 
participation in this research study. 
 
 
____________________________________ _________________________________ 
    
Parent’s Name      Relationship to Participant (Child) 
       
____________________________________ ________________________ 
Parent’s Signature     Date       
 
Children who can sign their name: 
 
This research has been explained to me, and I agree to participate. 
 
____________________________________  
Child’s Name  
 
____________________________________ ________________________ 
Child’s Signature     Date 
 
Verification of explanation for children who can sign their name: 
 
I certify that I have carefully explained the nature and purpose of this research study to the 
above-named child in age-appropriate language.  They have had an opportunity to discuss it with 
me in detail.  I have answered all their questions, and they have provided assent to participate in 
this study.  
 
 
____________________________________          __________________________________ 
Printed Name of Person Obtaining Consent  Role in Research Study 
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____________________________________ ________________________ 
Signature of Person Obtaining Consent  Date 
 
 
All participants:  
 
CERTIFICATION OF INFORMED CONSENT 
 
I certify that the nature and purpose of this research study have been explained to the above-
named individual(s), and the potential benefits and possible risks of study participation have 
been discussed. Any questions the individual(s) have about this study have been answered, and 
we will always be available to address future questions as they arise.  I further certify that no 
research component of this protocol was begun until after this consent form was signed. 
 
____________________________________  
Investigator’s Printed Name        
 
   
____________________________________ ________________________ 
Investigator’s Signature    Date 
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APPENDIX C 
STUDY PARTICIPANT CONSENT FORM FOR WEST VIRGINIA SITES 
        University of Pittsburgh 
        Institutional Review Board 
        Approval Date:  March 5, 2008 
        Renewal Date:   March 4, 2009 
        IRB #:  0506048 
 
CONSENT TO BE A SUBJECT IN A RESEARCH STUDY  
 
TITLE:   University of Pittsburgh: Coordinating Center for Genetic 
Factors Contributing to Oral Health Disparities in Appalachia 
 
PRINCIPAL              Mary L. Marazita, Ph.D., F.A.C.M.G. 
INVESTIGATOR: Professor, Oral/Maxillofacial Surgery; Assoc. Dean of Research 
School of Dental Medicine, University of Pittsburgh 
Suite 500 Cellomics Building/100 Technology Drive 
Pittsburgh,  PA   15219       USA 
Telephone:   412-648-8380  
 
CO-   Robert J. Weyant, D.M.D., Ph.D. 
INVESTIGATORS: Head, Division of Pediatric and Developmental Dental Sciences 
School of Dental Medicine, University of Pittsburgh  
Pittsburgh, PA   15261        
Telephone:  412-648-3076 
 
Katherine Neiswanger, Ph.D.  
Ph.D. Medical Geneticist 
School of Dental Medicine, University of Pittsburgh 
Suite 500 Cellomics Building, 100 Technology Drive 
Pittsburgh, PA   15219       USA 
Telephone:  412-648-8384 
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   [SITE COORDINATOR] 
   [NAME] 
   [ADDRESS] 
[PHONE] 
 
SOURCE OF SUPPORT: National Institute of Dental and Craniofacial Research, U.S.A. 
 
Why is this research being done? 
 
Dr. Marazita and Dr. Weyant invite you to be in a study to learn more about dental health in 
families, including behaviors, genes (those factors that determine a person’s physical 
characteristics and have been passed to them from their parents), and periodontal (gum tissue) 
factors.  Oral health varies greatly among different people.  The purpose of this study is to 
identify which genes, attitudes, and behaviors play a role in people’s oral health, so that risk 
factors for oral health problems can be better understood. 
________
_____  
Who is being asked to take part in this research study?  
 
You are a member of one of approximately 700 families from West Virginia or Western 
Pennsylvania with at least one child between 1 and 18 years old, who is being asked to 
participate in this study.  Your family is part of a representative sample of similar families in 
[NAME OF] County. 
 
What procedures are being performed for research purposes? 
 
You and your family will be asked to participate in a 4-part examination process during this visit.  
You and your family will also be asked to return every two years, for a total of three or four 
visits over five to seven years.  If you agree to participate, you will undergo the following 
procedures during this visit. You have the right to participate in only one, two, three, or all four 
parts of the examination: 
 
Part 1)  Questionnaires:  You will be asked a series of questions about your behaviors, 
thoughts, and opinions regarding dental health, general health, prevention, family relationships, 
parenting practices, social relationships, alcohol, drug and tobacco use, and mental health (for 
example, self esteem and mental illness).  Demographic information (for example, age) and 
general health history (for example, vaccinations and frequency of check ups) also will be 
recorded.  In addition, you will be asked to complete questionnaires that focus on medical 
symptoms, dental anxiety, and social history.  You will be given an opportunity to examine these 
questionnaires and do not have to answer all the questions. This part of the study will take about 
2 hours.   
Part 2) Dental, Microbiological and Tobacco Examinations:  You will be given a dental 
screening to document the presence of oral conditions, including dental decay (cavities), gum 
infections (called gingivitis and periodontitis by dentists), tooth alignment and crowding, dental 
or oral injury, and a variety of other conditions of the teeth and mouth (for example, thin 
enamel).  The dental exam will be conducted by a licensed dentist or dental hygienist and is 
similar to a routine checkup visit to a family dentist, except no x-rays will be taken.  During this 
exam, you will be asked questions regarding your dental status, such as history of tooth injury, 
and brushing and flossing habits. All people have different kinds of bacteria present in their 
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mouth, so the purpose of the oral microbiological exam is to test your saliva (“spit”) and the 
plaque on your teeth for bacteria that could cause cavities or gum infections.  For this 
examination, you will provide a saliva sample by chewing on a wax pellet and then spitting into 
a vial.  You will have a test to check the flow of your saliva.  Your saliva will also be used to 
check if there is any evidence of tobacco use.  A plastic strip will be placed on your tongue to 
collect saliva.  The inside of your cheek may also be scraped to collect a sample.  Dental 
instruments and special toothpicks will be used to scrape and collect dental plaque from your 
teeth and tongue.  A long Q-tip will be used to collect a throat swab from the back of your throat.   
If any dental problems are found, you will be given referral information and can seek dental care 
at your own expense.  Dental care will not be provided as part of this study. This part of the 
study will take about 1 hour. 
Part 3)   Blood sample for DNA studies:  Approximately one and one half teaspoons blood will 
be used to evaluate your DNA for genes relating to dental health, such as those which affect 
cavities, tooth development, or wound healing.  If you are unwilling to give a blood sample, you 
have the option of providing a saliva (spit) sample or having the inside of your cheek swabbed 
with several cotton swabs to collect cells that contain DNA.  If necessary, you could also be 
provided some mouthwash to rinse to collect the DNA.  This part of the study will take 5 
minutes or less, and will only be done at one visit, unless the sample is insufficient to complete 
the study. 
________
_____ 
Part 4) Water Sampling:  You have been sent a vial to collect a sample of your drinking water 
from your home.  This water will be tested for fluoride, a mineral in some people’s water that 
can prevent cavities.  Please bring this vial with you to your appointment.   
 
What are the possible risks, side effects, and discomforts of participating in this research study? 
 
1)  The questions in the interviews and questionnaires may be personal.  If any information about 
child abuse, neglect, or mistreatment is uncovered, then the law requires that it be reported.  
2)  The dental screening infrequently causes some slight gum bleeding, which usually stops 
within a few minutes. If you have a serious gum infection, you may be sensitive to the gum 
examination. There is a rare risk that probing your gums may cause an abscess, or infection, of 
the gum tissue. Although this is rare and usually goes away within a short period of time, it 
might be painful and require treatment with antibiotics.  
3) The gum examination is usually not a risky procedure for most healthy people.  But, if you 
have had previous bacterial (infective) endocarditis, certain specific and serious congenital 
(present from birth) heart conditions, or artificial heart valves or have had a knee or hip replaced, 
this examination could place you at risk for a bacterial infection that would affect your heart and 
the joints in your bones. You will be asked if you have ever had any of these heart or joint 
problems, and if so, you will be asked to obtain and take an antibiotic (either amoxicillin or 
clindamycin, azithromycin, or clarithromycin) at your own expense an hour before the gum 
examination. 
If you have the reduced ability to resist infection, this examination could place you at risk for 
developing an infection.  If you have the reduced ability to form blood clots, you could be at risk 
for mild, but prolonged bleeding during some of the exam procedures.  Prior to the dental exam, 
you will be asked in detail about having either of these conditions.  If you have a reduced ability 
to resist infection or form blood clots, you will be excused from all parts of the examination that 
might cause bleeding.  
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4)  Collection of tooth plaque, as well as the tongue and cheek scrapings, is likely to be briefly 
uncomfortable. The throat swab will likely lead to a brief gagging response.  
5)  The needle puncture of your vein to obtain the blood sample may infrequently result in pain 
and soreness, bruising, fainting, and rarely infection.  This procedure will be performed by 
individuals trained and experienced in obtaining blood samples so as to minimize these risks. 
6)  In the unlikely event of a breach of confidentiality, there is a very remote possibility that the 
genetic information could affect your ability to be insured, employed, or your family 
relationships.  Such problems are probably rare.  You can ask the investigators about the 
likelihood of the research discovering anything that would lead to these problems.  
 
What are the possible benefits of participating in this research study? 
  
By participating, you may learn more about your own dental and overall health.  You will 
receive verbal and written feedback about your dental screening.  If your dental screening reveals 
any significant problems, you will also receive names of some dentists or other health 
professionals who could help with any related dental/medical needs.   The information obtained 
from your participation in this research study may eventually lead to a better understanding and 
better treatments for oral health problems. 
________
_____ 
 
If I agree to take part in this research study, will I be told of any new risks that may be found 
during the course of this study? 
 
You will be promptly notified if any new information develops during the conduct of this 
research study, which may cause you to change your mind about continuing to participate. 
 
Will I or my insurance company be charged for the cost of any procedures performed as part of 
this research study? 
 
If you are required to obtain the prophylactic antibiotic from your family doctor, you or your 
insurance will be charged the cost of the antibiotic.  The study will reimburse any costs that you 
pay out-of-pocket to obtain the antibiotic.    
 
Will I be paid if I take part in this research study? 
 
You will be paid $5.00 for each procedure of the study that you complete, with an added $5.00 if 
all four procedures are completed, up to $25.00 for one visit.  Each time you return for the study 
(every 2 years for a total of 3 or 4 visits), you will be paid these same amounts.  Over a 5 – 7 
year period, you could potentially receive $75 - $100 dollars depending on the total number of 
visits.  You will also be reimbursed for any out-of-pocket expenses, including long distance 
communication, transportation, parking, one meal, prophylactic antibiotics, and any costs of 
obtaining a blood sample at a local lab. 
 
Who will pay if I am injured as a result of taking part in this study? 
 
University of Pittsburgh researchers recognize the importance of your voluntary participation in 
their research studies.  These individuals and their staffs will make reasonable efforts to 
minimize, control, and treat any injuries that may arise as a result of this research.  If you believe 
that you are injured as a result of the research procedures being performed, please contact 
immediately the Principal Investigator listed on the first page of this form. 
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Emergency medical treatment of injuries solely and directly related to your participation in this 
research study will be provided to you by the hospitals of UPMC.  It is possible that UPMC may 
bill your insurance provider for the costs of this emergency treatment, but none of these costs 
will be charged directly to you.  If your research-related injury requires medical care beyond this 
emergency, you will be responsible for the costs of this follow-up care unless otherwise 
specifically stated.  There is no plan for monetary compensation. You do not, however, waive 
any legal rights by signing this form. 
 
Who will know about my participation in this research study? 
 
Any information obtained about you from this research study will be kept as confidential as 
possible. All information about you or your involvement in this research study will only be 
accessible to the investigators involved in this study and their research staff, and will not be 
released to anyone without your written permission.  Records and information pertaining to your 
identity and involvement in this research study will be stored in locked file cabinets at the 
[School of Dentistry of the University of Pittsburgh OR LOCAL SITE]. Computer records will 
be kept in password protected, secured databases.  Your identity on data records, donated blood 
and dental samples, and DNA will be indicated only by code number. Records linking the codes 
to your personal identifying information will be stored in a separate, secure location.  You will 
not be identified by name in any publication of the research results unless you sign a separate 
form giving your permission. 
________
_____ 
 
Will this research study involve the use or disclosure of my identifiable medical information? 
 
This research study will NOT involve the use or disclosure of your identifiable medical 
information from your hospital or physician records, or future medical information that might 
become available during your participation in this study.  This study will record some of your 
personal health or medical information, which will be kept separate from your medical records, 
and used only for research purposes. 
 
Who will have access to identifiable information related to my participation in this research 
study? 
 
The information learned about you during this study will not be released to anyone (for example, 
relatives, personal physicians, insurance companies, or any other third party) without your prior 
written permission.   However, in the unlikely event that an interviewer identifies someone who 
is considered to be at immediate risk for harming him or herself or others, they will need to 
inform the appropriate agencies, as required by Pennsylvania law.  Any information about child 
abuse, neglect, or mistreatment must also be reported.  These research records, just like hospital 
records, may be subpoenaed by court order or may be inspected by federal regulatory authorities.   
In addition to the investigators listed on the first page of this consent form and their research 
staff, the following individuals may have access to identifiable information related to your 
participation in this research study.  Authorized representatives of the University of Pittsburgh 
Research Conduct and Compliance Office may review your identifiable research information for 
the purpose of monitoring the appropriate conduct of this research study.  In addition, authorized 
representatives of the University of Pittsburgh may have access to this information for the 
purpose of making participant payments.  
 
 80 
For how long will the investigators be permitted to use identifiable information related to my 
participation in this research study? 
 
The investigators may continue to use identifiable information related to your participation in 
this research study for at least 5 years following the completion of the research study. 
 
May I have access to my personal research information resulting from my participation in this 
research study? 
 
You will be notified if you have any dental problems.  You will not be provided with your 
personal research or genetic information obtained during this study.    
 
Is my participation in this study voluntary? 
 
Your participation in this research study is completely voluntary.  Whether or not you provide 
your consent for participation in this research study will have no effect on your current or future 
medical care at a UPMC Hospital or affiliated health care provider, or your current or future 
relationship with a health care insurance provider or with the University of Pittsburgh.  If you 
turn 18 during the course of the study, your parent’s permission is no longer valid, and you will 
be re-contacted to give permission as an adult. ________
_____ 
 
May I withdraw, at a future date, my consent for participation in this research study? 
 
You do not have to take part in this study and, should you change your mind, you can withdraw 
from the study at any time by submitting a dated, written request to withdraw to Dr. Marazita, 
who is listed on page 1 of this form.  Any research information recorded before your withdrawal 
may continue to be used in the research study.  Your decision to withdraw from this research 
study will have no effect on your current or future medical care at a UPMC Hospital or affiliated 
health care provider, or your current or future relationship with a health care insurance provider 
or with the University of Pittsburgh.  You may be removed from the study by the investigators, if 
the information you provide is incorrect.  If you withdraw or are removed from this research 
study, your biological samples, blood sample, and DNA will be destroyed.    
 
Will my DNA samples be used for future studies? 
 
Dr. Marazita will control the use of your biological samples and genetic material for this study, 
and will store your biological samples with codes in freezers at the University of Pittsburgh and 
West Virginia University.  In the future, new research may identify other factors that could be 
involved in oral health.  If this happens, Dr. Marazita would also like to examine them.  Thus, if 
you agree, your biological samples and DNA will be saved for future testing of newly identified 
factors involved in oral health.  When all of her research studies of oral health are completed, 
any remaining biological samples and DNA will be destroyed at that time.  If you do NOT agree, 
your biological samples and DNA will be discarded at the end of this particular research study.  
You may also be contacted in the future to be invited to participate in additional research, but 
that future involvement is voluntary as well.  If you turn 18 during the course of the study, your 
parent’s permission is no longer valid, and you will be re-contacted to give permission as an 
adult regarding the use of your DNA samples.  
Your blood sample and its DNA used in this research study may contribute to a new invention or 
discovery.  Sometimes, these inventions or discoveries may be of commercial value and may be 
sold, patented, or licensed by the investigators and the University of Pittsburgh for use in other 
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research or the development of new products related to oral health.  If the research investigators 
are able to develop new products from the use of your biological sample or genetic material, they 
currently have no plans to share any money or other rewards with you.  You retain the right to 
have your blood sample and its DNA destroyed if you decide to withdraw from this research 
study. 
************************************************************************************************************************************************
************ 
I give my permission for Dr. Marazita to save my biological samples and genetic material, 
with personal identifiers, for use in other genetic research projects involving the study of 
oral health. 
 
  YES ______    NO ________ 
I give my permission to be re-contacted to obtain my consent if there is a desire to use my 
biological sample or genetic material, with personal identifiers, in other research projects 
involving the study of different diseases or conditions. 
 
  YES ______    NO ________ 
 
 
________
_____ 
 
 
VOLUNTARY CONSENT AND AUTHORIZATION 
 
All of the above has been explained to me and all of my current questions have been answered.  I 
understand that I am encouraged to ask additional questions at any time about this research 
study, and that such future questions will be answered by the researchers listed on the first page 
of this form.  Any questions I have about my rights as a research participant will be answered by 
the Human Subject Protection Advocate of the IRB Office, University of Pittsburgh (1-866-212-
2668).   
 
By signing this form, I agree to participate in this research study. A copy of this consent form 
will be given to me. 
 
 
Adults aged 18 and over: 
 
 
____________________________________ ________________________ 
Participant’s Signature    Date 
 
      
Children aged 1 – 17: 
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I understand that, as a minor (age less than 18 years), 
_____________________________________ is not permitted to participate in this research 
study without my consent.  Therefore, by signing this form, I give my consent for their 
participation in this research study. 
 
 
____________________________________          __________________________________ 
Parent’s Name               Relationship to Participant (Child) 
 
        
____________________________________ ________________________ 
Parent’s Signature     Date       
 
Children who can sign their name: 
 
This research has been explained to me, and I agree to participate. 
 
____________________________________  
Child’s Name  
 
____________________________________ ________________________ 
Child’s Signature     Date 
 
Verification of explanation for children who can sign their name: 
 
I certify that I have carefully explained the nature and purpose of this research study to the 
above-named child in age-appropriate language.  They have had an opportunity to discuss it with 
me in detail.  I have answered all their questions, and they have provided assent to participate in 
this study.  
 
 
___________________________________       __________________________________ 
Printed Name of Person Obtaining Consent  Role in Research Study 
 
        
____________________________________ ________________________ 
Signature of Person Obtaining Consent  Date 
 
All participants:  
 
CERTIFICATION OF INFORMED CONSENT 
 
I certify that the nature and purpose of this research study have been explained to the above-
named individual(s), and the potential benefits and possible risks of study participation have 
been discussed. Any questions the individual(s) have about this study have been answered, and 
 83 
we will always be available to address future questions as they arise.  I further certify that no 
research component of this protocol was begun until after this consent form was signed. 
 
 
____________________________________  
Investigator’s Printed Name        
 
   
____________________________________ ________________________ 
Investigator’s Signature    Date 
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APPENDIX D 
INSTITUTIONAL REVIEW BOARD APPROVAL LETTER FOR WEST VIRGINIA 
SITES 
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APPENDIX E  
SCREENING INTERVIEW FORM PART 1, 2, AND 3-4 
 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
  99 
APPENDIX F 
DENTAL EXAMINATION FORM FOR AGE ≥ 18 
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APPENDIX G 
DENTAL EXAMINATION SUPPLEMENT FORM 
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APPENDIX H 
ALL RESULTS 
  PlaqSam1:PlaqSam1 PlaqSam1:PlaqSam2 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.1 0.12 * 370 369.6 0.04 
Parent:Offspring 2054 1430.5 -0.01 2054 1321.1 -0.07 * 
Sibling 885 565 0.23 *** 885 832.6 0.04 
Half-Sibling 271 195.4 0.18 * 271 354.1 0.01 
  PlaqSam1:PlaqSam3 PlaqSam1:PlaqSam4 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 368.9 -0.01 370 368.4 0.02 
Parent:Offspring 2054 1479.5 -0.11 *** 2054 1398.5 -0.12 *** 
Sibling 885 976.4 0.02 885 939.4 -0.03 
Half-Sibling 271 376.5 -0.003 271 342.2 -0.04 
  PlaqSam1:PlaqSam5 Plaqsam2:PlaqSam1 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 -0.03 370 367.7 0.08 
Parent:Offspring 2054 1566.9 0.01 2054 1239.1 -0.04 
Sibling 885 793 0.16 *** 885 832.6 0.04 
Half-Sibling 271 276.5 0.144 * 271 354.1 0.01 
  PlaqSam2:PlaqSam2 PlaqSam2:PlaqSam3 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.6 0.37 *** 370 369.4 0.20 *** 
Parent:Offspring 2054 1162.6 0.23 *** 2054 1290.1 0.07 * 
Sibling 885 489.9 0.33 *** 885 811.2 0.12 *** 
Half-Sibling 271 187 0.08 271 335.1 0.1 
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  PlaqSam2:PlaqSam4 PlaqSam2:PlaqSam5 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 368.4 0.09 370 369.9 0.06 
Parent:Offspring 2054 1214.7 -0.05 2054 1358.5 -0.05 
Sibling 885 822.5 0.11 *** 885 943.4 -0.02 
Half-Sibling 271 344.2 0.03 271 389.7 0.003 
  PlaqSam3:PlaqSam1 PlaqSam3:PlaqSam2 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 368.6 0.03 370 369 0.20 *** 
Parent:Offspring 2054 1320.1 0.05 2054 1225.8 0.11 
Sibling 885 976.4 0.02 885 811.2 0.12 *** 
Half-Sibling 271 376.5 -0.003 271 335.1 0.1 
  PlaqSam3:PlaqSam3 PlaqSam3:PlaqSam4 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.4 0.24 *** 370 369.9 0.13 * 
Parent:Offspring 2054 1392.8 0.14 *** 2054 1304.9 0.002 
Sibling 885 585.4 0.20 *** 885 914.5 0.11 *** 
Half-Sibling 271 210.1 0.09 271 342 0.07 
  PlaqSam3:PlaqSam5 PlaqSam4:PlaqSam1 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 365.2 0.11 * 370 368 -0.04 
Parent:Offspring 2054 1256.9 0.02 2054 1327.5 0.02 
Sibling 885 1090.7 0.01 885 939.4 -0.03 
Half-Sibling 271 411.3 -0.02 271 342.2 -0.04 
  PlaqSam4:PlaqSam2 PlaqSam4:PlaqSam3 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.4 0.07 370 368.2 0.15 ** 
Parent:Offspring 2054 1227.8 0.04 2054 1386.1 0.05 
Sibling 885 822.5 0.11 *** 885 914.5 0.11 *** 
Half-Sibling 271 344.2 0.03 271 342 0.07 
  PlaqSam4:PlaqSam4 PlaqSam4:PlaqSam5 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.3 0.24 *** 370 369.6 -0.02 
Parent:Offspring 2054 1304.7 0.07 ** 2054 1463.3 -0.01 
Sibling 885 555.6 0.24 *** 885 1055.3 -0.05 
Half-Sibling 271 192.1 0.21 ** 271 380.9 -0.05 
  PlaqSam5:PlaqSam1 PlaqSam5:PlaqSam2 
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  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 -0.03 370 367.7 0.1 
Parent:Offspring 2054 1559.9 0.002 2054 1444 0.02 
Sibling 885 793 0.16 *** 885 943.4 -0.02 
Half-Sibling 271 276.5 0.144 * 271 389.7 0.003 
  PlaqSam5:PlaqSam3 PlaqSam5:PlaqSam4 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.4 0.01 370 365.7 -0.10 * 
Parent:Offspring 2054 1623.6 0.04 2054 1535.1 -0.05 * 
Sibling 885 1090.7 0.01 885 1055.3 -0.05 
Half-Sibling 271 411.3 -0.02 271 380.9 -0.05 
  PlaqSam5:PlaqSam5   
  count equiv count correlation     
Mother:Father 370 369 -0.02     
Parent:Offspring 2054 1703.3 0.01     
Sibling 885 642.4 0.15 ***     
Half-Sibling 271 219.2 0.1     
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0242 – 0.0729 
  TestR:TestR TestR:SupTestR 
  count equiv count correlation count equiv count correlation 
Mother:Father 359 357.9 -0.01 74 1.2 0.06 *** 
Parent:Offspring 1051 1096.5 0.02 355 11.9 -0.08 
Sibling 383 273.8 -0.03 96 41.6 0.01 
Half-Sibling 93 93.3 -0.02 68 2.7 -0.04 *** 
  TestR:SupTestR2 TestR:SupTestR3 
  count equiv count correlation count equiv count correlation 
Mother:Father 21 1 0.18 *** 34 1 0.23 *** 
Parent:Offspring 87 1.1 0.12 *** 94 1.1 0.13 *** 
Sibling 26 1 0.19 ***^ 25 8.3 -0.06 
Half-Sibling 22 1.2 -0.11 *** 17 1.3 -0.18 *** 
  TestR:SupTestR4 SupTestR:TestR 
  count equiv count correlation count equiv count correlation 
Mother:Father 30 1 0.29 *** 68 8.5 -0.18 
Parent:Offspring 55 1.1 0.15 *** 223 35.2 -0.03 
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Sibling 15 1 -0.07 *** 96 41.6 0.01 
Half-Sibling 9 1.2 -0.24 *** 68 2.7 -0.04 *** 
  SupTestR:SupTestR SupTestR:SupTestR2 
  count equiv count correlation count equiv count correlation 
Mother:Father 66 14.2 0.21 19 1.6 0.17 *** 
Parent:Offspring 331 57.1 0.09 74 1.2 -0.26 *** 
Sibling 127 21.5 0.44 * 31 2.3 -.28 *** 
Half-Sibling 103 44 0.13 35 12.2 -0.01 
  SupTestR:SupTestR3 SupTestR:SupTestR4 
  count equiv count correlation count equiv count correlation 
Mother:Father 29 2.6 -0.03 *** 25 2.6 0.33 *** 
Parent:Offspring 81 1.2 -0.09 *** 48 1.2 -0.19 *** 
Sibling 32 5.7   22 1.9 -0.05 *** 
Half-Sibling 29 8.8 -0.31 16 5 -0.51 
  SupTestR2:TestR SupTestR2:SupTestR 
  count equiv count correlation count equiv count correlation 
Mother:Father 25 1 0.15 *** 25 2.1 0.05 *** 
Parent:Offspring 55 5.8 -0.04 97 5.1 0.01 
Sibling 26 1 0.19 ***^ 31 2.3 -.28 *** 
Half-Sibling 22 1.2 -0.11 *** 35 12.2 -0.01 
  SupTestR2:SupTestR2 SupTestR2:SupTestR3 
  count equiv count correlation count equiv count correlation 
Mother:Father 11 1.3 0.13 *** 14 1.5 0.17 *** 
Parent:Offspring 33 1 0.02 ***^ 26 1 -0.01 ***^ 
Sibling 20 1 0.25 ***^ 11 1 0.16 ***^ 
Half-Sibling 13 1.8 -0.17 12 1 0.21 *** 
  SupTestR2:SupTestR4 SupTestR3:TestR 
  count equiv count correlation count equiv count correlation 
Mother:Father 9 1.2 0.69 *** 26 1 0.11 *** 
Parent:Offspring 19 1 -0.08 ***^ 94 4.9 -0.03 
Sibling 8 1 0.13 ***^ 25 8.3 -0.06 
Half-Sibling 6 1 -0.26 ***^ 17 1.3 -0.18 *** 
  SupTestR3:SupTestR SupTestR3:SupTestR2 
  count equiv count correlation count equiv count correlation 
Mother:Father 27 3.2 0.64 7 1.2 0.34 *** 
Parent:Offspring 149 12.2 0.03 38 1 0.26 ***^ 
Sibling 31 2.3 -.28 *** 11 1 0.16 ***^ 
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Half-Sibling 29 8.8 -0.31 12 1 0.21 *** 
  SupTestR3:SupTestR3 SupTestR3:SupTestR4 
  count equiv count correlation count equiv count correlation 
Mother:Father 16 1.7 0.18 *** 13 1.6 0.52 *** 
Parent:Offspring 43 1.1 -0.03 *** 30 1.1 -0.17 *** 
Sibling 7 1 0.10 ***^ 8 1 -0.07 ***^ 
Half-Sibling 9 1 0.36 ***^ 4 1 0.03 ***^ 
  SupTestR4:TestR SupTestR4:SupTestR 
  count equiv count correlation count equiv count correlation 
Mother:Father 24 1 -0.08 *** 23 2.5 0.51 *** 
Parent:Offspring 73 1 -0.21 *** 113 7.9 0.05 
Sibling 15 1 -0.07 *** 22 1.9 -0.05 *** 
Half-Sibling 9 1.2 -0.24 *** 16 5 -0.51 
  SupTestR4:SupTestR2 SupTestR4:SupTestR3 
  count equiv count correlation count equiv count correlation 
Mother:Father 7 1.2 0.31 *** 14 1.9 0.55 *** 
Parent:Offspring 25 1 -0.01 ***^ 38 1 0.26 ***^ 
Sibling 8 1 0.13 ***^ 8 1 -0.07 ***^ 
Half-Sibling 6 1 -0.26 ***^ 4 1 0.23 ***^ 
  SupTestR4:SupTestR4    
  count equiv count correlation    
Mother:Father 13 1.5 0.27 ***    
Parent:Offspring 25 1 0.13    
Sibling 5 1 -0.29 ***    
Half-Sibling 4 1 -0.09 ***^    
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
^ p ≥ 10.0 
Standard error range for correlation values included in table: 0.0302 – ≥ 10.0 
  TungRes:TungRes TungRes:Btest03 
  count equiv count correlation count equiv count correlation 
Mother:Father 359 338.8 0.44 *** 337 299.7 -0.04 
Parent:Offspring 1855 954.8 0.34 *** 1019 231.1 -0.06 
Sibling 776 392.7 0.39 *** 470 140.2 0.001 
Half-Sibling 248 148 0.28 *** 149 86 0.05 
  TungRes:Btest14 TungRes:Btest19 
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  count equiv count correlation count equiv count correlation 
Mother:Father 337 300.9 -0.01 346 312.7 -0.06 
Parent:Offspring 1019 245.1 -0.07 1021 232.2 -0.06 
Sibling 469 152 -0.01 471 144.2 0.03 
Half-Sibling 149 87.2 0.05 147 82 0.05 
  TungRes:Btest30 Btest03:TungRes 
  count equiv count correlation count equiv count correlation 
Mother:Father 346 323.2 -0.07 353 305.4 0.09 
Parent:Offspring 1022 267 -0.05 1774 1003.3 0.02 
Sibling 472 191.4 0.03 470 140.2 0.001 
Half-Sibling 147 89 0.08 149 86 0.05 
  Btest03:Btest03 Btest03:Btest14 
  count equiv count correlation count equiv count correlation 
Mother:Father 335 304.7 0.07 335 304.6 0.07 
Parent:Offspring 970 397.3 0.10 * 970 395.9 0.09 
Sibling 357 142.9 0.37 *** 356 145.6 0.36 *** 
Half-Sibling 91 21.4 0.31 91 22.9 0.31 
  Btest03:Btest19 Btest03:Btest30 
  count equiv count correlation count equiv count correlation 
Mother:Father 344 311.5 0.13 * 344 313.4 0.07 
Parent:Offspring 971 392.4 0.08 972 413.9 0.09 
Sibling 358 151.5 0.38 *** 358 158.6 0.32 *** 
Half-Sibling 89 21.2 0.31 89 25 0.28 
  Btest14:TungRes Btest14:Btest03 
  count equiv count correlation count equiv count correlation 
Mother:Father 353 309.3 0.06 335 305.8 0.07 
Parent:Offspring 1772 992.2 0.02 969 417.6 0.12 * 
Sibling 469 152 -0.01 356 145.6 0.36 *** 
Half-Sibling 149 87.2 0.05 91 22.9 0.31 
  Btest14:Btest14 Btest14:Btest19 
  count equiv count correlation count equiv count correlation 
Mother:Father 335 305.7 0.06 344 312.9 0.12 * 
Parent:Offspring 969 418.5 0.12 * 970 414.1 0.12 * 
Sibling 355 142.9 0.37 *** 357 147.3 0.37 *** 
Half-Sibling 91 21.8 0.3 89 21.8 0.3 
  Btest14:Btest30 Btest19:TungRes 
  count equiv count correlation count equiv count correlation 
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Mother:Father 344 314.5 0.06 359 328 0.03 
Parent:Offspring 971 438 0.14 ** 1821 998 0.03 
Sibling 357 154.2 0.31 *** 471 144.2 0.03 
Half-Sibling 89 25.7 0.27 147 82 0.05 
  Btest19:Btest03 Btest19:Btest14 
  count equiv count correlation count equiv count correlation 
Mother:Father 341 317.4 0.09 341 317.2 0.09 
Parent:Offspring 1006 398.2 0.1 1006 410.2 0.09 
Sibling 358 151.5 0.38 *** 357 147.3 0.37 *** 
Half-Sibling 89 21.2 0.31 89 21.8 0.3 
  Btest19:Btest19 Btest19:Btest30 
  count equiv count correlation count equiv count correlation 
Mother:Father 350 325 0.16 ** 350 326.3 0.1 
Parent:Offspring 1008 397 0.09 1009 419.2 0.10 * 
Sibling 359 126.5 0.38 *** 359 136.7 0.32 *** 
Half-Sibling 88 17.1 0.3 88 20.6 0.27 
  Btest30:TungRes Btest30:Btest03 
  count equiv count correlation count equiv count correlation 
Mother:Father 359 331.7 0.03 341 319.9 0.08 
Parent:Offspring 1821 1049.7 0.05 1006 393.1 0.09 
Sibling 472 191.4 0.03 358 158.6 0.32 *** 
Half-Sibling 147 89 0.08 89 25 0.28 
  Btest30:Btest14 Btest30:Btest19 
  count equiv count correlation count equiv count correlation 
Mother:Father 341 319.8 0.08 350 327.1 0.14 * 
Parent:Offspring 1006 405.8 0.11 * 1008 390.8 0.10 * 
Sibling 357 154.2 0.31 *** 359 136.7 0.32 *** 
Half-Sibling 89 25.7 0.27 88 20.6 0.27 
  Btest30:Btest30  
  count equiv count correlation    
Mother:Father 350 329 0.08    
Parent:Offspring 1009 412.6 0.11 *    
Sibling 359 128.9 0.27 **    
Half-Sibling 88 21.7 0.25    
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0286 – 0.2301 
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  permgenDMFS:permgenDMFS pergenDMFS:permgenDMFT 
  count equiv count correlation count equiv count correlation 
Mother:Father 227 226.5 0.27 *** 228 227.4 0.23 *** 
Parent:Offspring 795 370.8 0.25 *** 795 621.3 0.32 *** 
Sibling 311 121.7 0.19 * 311 236.9 0.24 *** 
Half-sibling 57 25.2 0.38 57 52.6 0.22 
  permgeDMFS:permconseverDMFS pergenDMFS:permconservDMFT 
  count equiv count correlation count equiv count correlation 
Mother:Father 228 227.5 0.11 228 232.1 0.08 
Parent:Offspring 795 300.4 0.31 *** 795 317.3 0.30 *** 
Sibling 311 153.7 0.20 * 311 165 0.23 ** 
Half-sibling 57 34.9 0.14 57 35.4 0.08 
  permgenDMFT:permgenDMFS permgenDMFT:permgenDMFT 
  count equiv count correlation count equiv count correlation 
Mother:Father 227 227.6 0.21 ** 228 228.1 0.16 * 
Parent:Offspring 795 355.9 0.23 *** 795 598.6 0.28 *** 
Sibling 311 236.9 0.24 *** 311 263.8 0.36 *** 
Half-sibling 57 52.6 0.22 57 67.6 0.11 
  permgenDMFT:permconservDMFS permgenDMFT:permconservDMFT 
  count equiv count correlation count equiv count correlation 
Mother:Father 228 228.3 0.1 228 233.2 0.04 
Parent:Offspring 795 295.6 0.24 *** 795 311 0.25 *** 
Sibling 311 259.5 0.36 *** 311 253.3 0.38 *** 
Half-sibling 57 55.2 0.04 57 53 0.01 
  permconservDMFS:permgenDMFS permconservDMFS:permgenDMFT 
  count equiv count correlation count equiv count correlation 
Mother:Father 227 225.6 0.13 * 228 227.7 0.1 
Parent:Offspring 795 367 0.08 795 619.4 0.12 ** 
Sibling 311 153.7 0.20 * 311 259.5 0.36 *** 
Half-sibling 57 34.9 0.14 57 55.2 0.04 
  permconservDMFS:permconservDMFS permconservDMFS:permconservDMFT
  count equiv count correlation count equiv count correlation 
Mother:Father 228 227.1 0.16 * 228 232.2 0.1 
Parent:Offspring 795 308.1 0.1 795 325.5 0.12 * 
Sibling 311 129.2 0.42 *** 311 143.6 0.43 *** 
Half-sibling 57 26.3 -0.04 57 28.3 -0.04 
  permconservDMFT:permgenDMFS permconservDMFT:permgenDMFT 
  count equiv count correlation count equiv count correlation 
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Mother:Father 227 231.6 0.08 228 234.1 0.05 
Parent:Offspring 795 377.3 0.07 795 635.5 0.09 * 
Sibling 311 165 0.023 ** 311 253.3 0.38 *** 
Half-sibling 57 35.4 0.08 57 53 0.01 
  permconserveDMFT:permconservDMFS permconservDMFT:permconservDMFT
  count equiv count correlation count equiv count correlation 
Mother:Father 228 233.1 0.1 228 236.3 0.03 
Parent:Offspring 795 318.2 0.05 795 333.1 0.07 
Sibling 311 143.6 0.43 *** 311 132.6 0.44 *** 
Half-sibling 57 28.3 -0.04 57 25.8 -0.04 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0362 – 0.2006 
  BL03:BL03 BL03:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.15 ** 370 370.1 0.16 ** 
Parent:Offspring 1082 776.3 0.15 *** 1082 767.3 0.15 *** 
Sibling 387 262.8 0.24 *** 387 271.9 0.25 *** 
Half-Sibling 93 74.7 0.26 * 93 77.9 0.25 * 
  BL03:BL19 BL03:BL30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 364.9 0.2 *** 370 368.5 0.17 *** 
Parent:Offspring 1082 809.3 0.14 *** 1082 328.7 0.16 *** 
Sibling 387 309.2 0.22 *** 387 319.9 0.20 *** 
Half-Sibling 93 87.8 0.2 93 90.1 0.25 * 
  BL14:BL03 BL14:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 367.8 0.18 *** 370 369.1 0.19 *** 
Parent:Offspring 1082 760.1 0.16 *** 1082 751 0.16 *** 
Sibling 387 271.9 0.25 *** 387 257.6 0.26 *** 
Half-Sibling 93 77.9 0.25 * 93 73.8 0.25 * 
  BL14:BL19 BL14:BL30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 358.9 0.26 *** 370 364.5 0.23 *** 
Parent:Offspring 1082 791.8 0.15 *** 1082 811.1 0.17 *** 
Sibling 387 311.7 0.21 *** 387 322.7 0.19 *** 
Half-Sibling 93 88.8 0.2 93 91.1 0.25 * 
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  BL19:BL03 BL19:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 371.9 0.15 ** 370 375 0.16 ** 
Parent:Offspring 1082 748.5 0.16 *** 1082 739 0.17 *** 
Sibling 387 309.2 0.22 *** 387 311.7 0.21 *** 
Half-Sibling 93 87.8 0.2 93 88.8 0.2 
  BL19:BL19 BL19:BL30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.22 *** 370 372.5 0.18 *** 
Parent:Offspring 1082 782.9 0.18 *** 1082 802.8 0.20 *** 
Sibling 387 275.4 0.21 *** 387 299.5 0.19 ** 
Half-Sibling 93 76.5 0.15 93 82.8 0.2 
  BL30:BL03 BL30:BL14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.3 0.16 ** 370 372.5 0.17 *** 
Parent:Offspring 1082 758.9 0.18 *** 1082 749.4 0.18 *** 
Sibling 387 319.9 0.20 *** 387 322.7 0.19 *** 
Half-Sibling 93 90.1 0.25 * 93 91.1 0.25 * 
  BL30:BL19 BL30:BL30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 364.4 0.24 *** 370 368.9 0.20 *** 
Parent:Offspring 1082 794.6 0.19 *** 1082 814.4 022 *** 
Sibling 387 299.5 0.19 ** 387 291.2 0.17 ** 
Half-Sibling 93 82.8 0.2 93 79.4 0.25 * 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0334 – 0.1126 
  PSR03:PSR03 PSR03:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.16 ** 370 370.8 0.17 ** 
Parent:Offspring 1082 767.2 0.16 *** 1082 779.3 0.16 *** 
Sibling 387 260.6 0.25 *** 387 268.4 0.24 *** 
Half-Sibling 93 74.4 0.26 * 93 76.3 0.24 * 
  PSR03:PSR19 PSR03:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 364.2 0.23 *** 370 366.9 0.19 *** 
Parent:Offspring 1082 794.7 0.16 *** 1082 809.9 0.15 *** 
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Sibling 387 2998.2 0.23 *** 387 305.5 0.22 *** 
Half-Sibling 93 85 0.24 * 93 86.5 0.24 * 
  PSR14:PSR03 PSR14:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 367 0.20 *** 370 369.1 0.20 *** 
Parent:Offspring 1082 749.4 0.16 *** 1082 761.1 0.16 *** 
Sibling 387 268.4 0.24 *** 387 265.1 0.24 *** 
Half-Sibling 93 76.3 0.24 * 93 74.9 0.22 
  PSR14:PSR19 PSR14:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 363.5 0.24 *** 370 366.4 0.21 *** 
Parent:Offspring 1082 774.8 0.16 *** 1082 789.7 0.14 *** 
Sibling 387 305.5 0.23 *** 387 314.4 0.21 *** 
Half-Sibling 93 86.7 0.22 * 93 88.7 0.22 * 
  PSR19:PSR03 PSR19:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 372.6 0.17 *** 370 373.2 0.18 *** 
Parent:Offspring 1082 737.8 0.16 *** 1082 748.2 0.16 *** 
Sibling 387 2998.2 0.23 *** 387 305.5 0.23 *** 
Half-Sibling 93 85 0.24 * 93 86.7 0.22 * 
  PSR19:PSR19 PSR19:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.1 0.24 *** 370 371.1 0.21 *** 
Parent:Offspring 1082 762.9 0.18 *** 1082 778.4 0.17 *** 
Sibling 387 271.2 0.22 *** 387 288.2 0.20 *** 
Half-Sibling 93 75.9 0.22 93 80.3 0.22 
  PSR30:PSR03 PSR30:PSR14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 370.7 0.17 ** 370 371.1 0.17 *** 
Parent:Offspring 1082 753 0.17 *** 1082 763.6 0.17 *** 
Sibling 387 305.5 0.22 *** 387 314.4 0.21 *** 
Half-Sibling 93 86.5 0.24 * 93 88.7 0.22 * 
  PSR30:PSR19 PSR30:PSR30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 366.6 0.23 *** 370 368.9 0.20 *** 
Parent:Offspring 1082 779.4 0.19 *** 1082 795 0.18 *** 
Sibling 387 288.2 0.20 *** 387 280.4 0.19 ** 
Half-Sibling 93 80.3 0.22 93 77.4 0.22 
* 0.01 ≤ p ≤ 0.05 
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** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0343 – 0.1111 
  REC03:REC03 REC03:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369 0.16 ** 370 370.9 0.17 ** 
Parent:Offspring 1082 753.4 0.16 *** 1082 766.5 0.19 *** 
Sibling 387 250.7 0.28 *** 387 260.8 0.27 *** 
Half-Sibling 93 72.5 0.26 * 93 75.2 0.26 * 
  REC03:REC19 REC03:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 365.1 0.22 *** 370 368.4 0.18 *** 
Parent:Offspring 1082 794.4 0.15 *** 1082 810.9 0.15 *** 
Sibling 387 290.4 0.26 *** 387 300.4 0.24 *** 
Half-Sibling 93 83.4 0.2 93 85.8 0.24 * 
  REC14:REC03 REC14:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 366.8 0.20 *** 370 369.1 0.20 *** 
Parent:Offspring 1082 736.8 0.16 *** 1082 749.9 0.17 *** 
Sibling 387 260.8 0.27 *** 387 257.1 0.26 *** 
Half-Sibling 93 75.2 0.26 * 93 73.7 0.26 * 
  REC14:REC19 REC14:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 361 0.26 *** 370 365.6 0.22 *** 
Parent:Offspring 1082 777 0.15 *** 1082 793.4 0.16 *** 
Sibling 387 297.8 0.25 *** 387 309.5 0.23 *** 
Half-Sibling 93 85.4 0.2 93 88.1 0.24 * 
  REC19:REC03 REC19:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 372.1 0.17 *** 370 374.5 0.18 *** 
Parent:Offspring 1082 722.6 0.16 *** 1082 735.3 0.18 *** 
Sibling 387 290.4 0.26 *** 387 297.8 0.25 *** 
Half-Sibling 93 83.4 0.2 93 85.4 0.2 
  REC19:REC19 REC19:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.1 0.23 *** 370 371.8 0.19 *** 
Parent:Offspring 1082 764.4 0.17 *** 1082 780.7 0.18 *** 
Sibling 387 267.1 0.23 *** 387 285 0.21 *** 
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Half-Sibling 93 75 0.15 93 79.7 0.18 
  REC30:REC03 REC30:REC14 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 369.5 0.17 *** 370 371.8 0.18 *** 
Parent:Offspring 1082 740 0.17 *** 1082 753 0.19 *** 
Sibling 387 300.4 0.24 *** 387 309.5 0.23 *** 
Half-Sibling 93 85.8 0.24 * 93 88.1 0.24 * 
  REC30:REC19 REC30:REC30 
  count equiv count correlation count equiv count correlation 
Mother:Father 370 365.5 0.23 *** 370 368.9 0.19 *** 
Parent:Offspring 1082 782.6 0.18 *** 1082 799.3 0.19 *** 
Sibling 387 285 0.21 *** 387 278.7 0.20 *** 
Half-Sibling 93 79.7 0.18 93 77.2 0.22 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
Standard error range for correlation values included in table: 0.0342 – 0.1136 
  S1b:S1b S1b:S2b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.1 0.12 * 369 368.4 0.12 * 
Parent:Offspring 67 58.8 0.01 67 61.2 0.04 
Sibling 3 NE 1 3 6.5 0.71 
Half-Sibling NI NI NI NI NI NI 
  S1b:S3b S1b:S4b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.7 0.13 * 369 366.9 0.17 ** 
Parent:Offspring 67 61.1 0.05 67 60 -0.09 
Sibling 3 6.5 0.71 3 7.5 0.71 
Half-Sibling NI NI NI NI NI NI 
  S1b:S5b S1b:S6b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 365.8 0.18 *** 369 379.2 0.15 ** 
Parent:Offspring 67 63.2 0.05 67 60.2 -0.09 
Sibling 3 6.3 0.25 3 7.3 0.71 
Half-Sibling NI NI NI NI NI NI 
  S2b:S1b S2b:S2b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.8 0.13 * 369 368.1 0.13 * 
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Parent:Offspring 67 58.6 0.04 67 61 0.06 
Sibling 3 6.5 0.71 3 3.8 0.33 
Half-Sibling NI NI NI NI NI NI 
  S2b:S3b S2b:S4b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.3 0.14 ** 369 366.3 0.17 *** 
Parent:Offspring 67 60.9 0.07 67 60.1 -0.08 
Sibling 3 4.1 0.33 3 4.3 0.33 
Half-Sibling NI NI NI NI NI NI 
  S2b:S5b S2b:S6b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 365.2 0.19 *** 369 378.9 0.16 ** 
Parent:Offspring 67 62.5 0.07 67 60.2 -0.08 
Sibling 3 NE NE 3 4.3 0.33 
Half-Sibling NI NI NI NI NI NI 
  S3b:S1b S3b:S2b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.2 0.11 * 369 369.4 0.11 * 
Parent:Offspring 67 68.2 0.02 67 60.6 0.05 
Sibling 3 6.5 0.71 3 4.1 0.33 
Half-Sibling NI NI NI NI NI NI 
  S3b:S3b S3b:S4b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.1 0.14 ** 369 367.2 0.15 ** 
Parent:Offspring 67 60.6 0.06 67 59.8 -0.09 
Sibling 3 3.8 0.33 3 4.4 0.33 
Half-Sibling NI NI NI NI NI NI 
  S3b:S5b S3b:S6b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.4 0.17 ** 369 379.3 0.14 ** 
Parent:Offspring 67 62.4 0.06 67 59.9 -0.08 
Sibling 3 NE NE 3 4.3 0.33 
Half-Sibling NI NI NI NI NI NI 
  S4b:S1b S4b:S2b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.3 0.15 ** 369 369.7 0.15 ** 
Parent:Offspring 67 56 -0.03 67 58.2 -0.10 
Sibling 3 7.5 0.71 3 4.3 0.33 
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Half-Sibling NI NI NI NI NI NI 
  S4b:S3b S4b:S4b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369 0.14 ** 369 368.3 0.19 *** 
Parent:Offspring 67 58.3 -0.09 67 54.3 -0.06 
Sibling 3 4.4 0.33 3 3.8 0.33 
Half-Sibling NI NI NI NI NI NI 
  S4b:S5b S4b:S6b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.2 0.21 *** 369 379.3 0.17 *** 
Parent:Offspring 67 58.4 -0.09 67 55.5 -0.06 
Sibling 3 NE NE 3 4 0.33 
Half-Sibling NI NI NI NI NI NI 
  S5b:S1b S5b:S2b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 370.1 0.15 ** 369 370.5 0.15 ** 
Parent:Offspring 67 55.4 -0.04 67 57 -0.10 
Sibling 3 6.3 0.25 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S5b:S3b S5b:S4b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.6 0.14 ** 369 369.4 0.19 *** 
Parent:Offspring 67 57.2 -0.09 67 55.4 -0.06 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S5b:S5b S5b:S6b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.4 0.21 *** 369 380.2 0.18 *** 
Parent:Offspring 67 58.6 -0.09 67 56.3 -0.06 
Sibling 3 4.3 -0.50 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S6b:S1b S6b:S2b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.3 0.16 ** 369 369.7 0.17 ** 
Parent:Offspring 67 58.5 -0.06 67 60.8 -0.11 
Sibling 3 7.3 0.71 3 4.3 0.33 
Half-Sibling NI NI NI NI NI NI 
  S6b:S3b S6b:S4b 
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  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.1 0.15 ** 369 369.4 0.19 *** 
Parent:Offspring 67 60.9 -0.11 67 58.8 -0.07 
Sibling 3 4.3 0.33 3 4 0.33 
Half-Sibling NI NI NI NI NI NI 
  S6b:S5b S6b:S6b 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.4 0.20 *** 369 379.5 0.17 ** 
Parent:Offspring 67 62.7 -0.11 67 59.4 -0.07 
Sibling 3 NE NE 3 3.8 0.33 
Half-Sibling NI NI NI NI NI NI 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
NE Value is not estimable 
NI No results produced 
Standard error range for correlation values included in table: 0.0498 – 0.5826 
  S1:S1 S1:S2 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 68 0.05 369 368.6 0.03 
Parent:Offspring 67 65.3 0.02 67 66.5 0.05 
Sibling 3 3.5 -0.20 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S1:S3 S1:S4 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.7 0.05 369 368.4 0.08 
Parent:Offspring 67 65.3 0.05 67 68.5 -0.08 
Sibling 3 3.7 -0.20 3 6.4 -0.76 
Half-Sibling NI NI NI NI NI NI 
  S1:S5 S1:S6 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.9 0.07 369 378.7 0.05 
Parent:Offspring 67 65.5 -0.08 67 67 -0.16 
Sibling 3 3.8 0.11 3 4.3 -0.32 
Half-Sibling NI NI NI NI NI NI 
  S2:S1 S2:S2 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 365.9 0.09 369 368 0.04 
Parent:Offspring 67 65.8 0.05 67 67 0.08 
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Sibling 3 NE NE 3 4.3 -0.50 
Half-Sibling NI NI NI NI NI NI 
  S2:S3 S2:S4 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.1 0.09 369 365.6 0.12 * 
Parent:Offspring 67 65.7 0.08 67 67.4 -0.07 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S2:S5 S2:S6 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.9 0.08 369 377.9 0.07 
Parent:Offspring 67 64.7 -0.07 67 66.2 -0.14 
Sibling 3 3.3 0.3 3 2.8 0.43 *** 
Half-Sibling NI NI NI NI NI NI 
  S3:S1 S3:S2 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.8 0.09 369 368.6 0.07 
Parent:Offspring 67 64 0.03 67 65.2 0.06 
Sibling 3 3.7 -0.20 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S3:S3 S3:S4 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368 0.09 369 368 0.1 
Parent:Offspring 67 64 0.06 67 67.5 -0.07 
Sibling 3 3.5 -0.20 3 6.5 -0.76 
Half-Sibling NI NI NI NI NI NI 
  S3:S5 S3:S6 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.7 0.09 369 378.5 0.07 
Parent:Offspring 67 64.5 -0.08 67 66.2 -0.15 
Sibling 3 3.8 0.11 3 4.4 -0.32 
Half-Sibling NI NI NI NI NI NI 
  S4:S1 S4:S2 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.6 0.09 369 369.4 0.07 
Parent:Offspring 67 63.1 -0.004 67 62.8 -0.09 
Sibling 3 6.4 -0.76 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
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  S4:S3 S4:S4 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.1 0.1 369 368.2 0.15 ** 
Parent:Offspring 67 36.1 -0.09 67 64.6 -0.04 
Sibling 3 6.5 -0.76 3 6.2 -0.76 * 
Half-Sibling NI NI NI NI NI NI 
  S4:S5 S4:S6 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 370.6 0.11 * 369 378.8 0.09 
Parent:Offspring 67 60.7 -0.06 67 63.4 -0.10 
Sibling 3 5 -0.65 3 5.9 -0.69 
Half-Sibling NI NI NI NI NI NI 
  S5:S1 S5:S2 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.8 0.11 * 369 368.2 0.08 
Parent:Offspring 67 63.7 -0.01 67 63.4 -0.08 
Sibling 3 3.8 0.11 3 3.3 0.3 
Half-Sibling NI NI NI NI NI NI 
  S5:S3 S5:S4 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.4 0.11 * 369 364.4 0.17 ** 
Parent:Offspring 67 63.8 -0.09 67 64 -0.04 
Sibling 3 3.8 0.11 3 5 -0.65 
Half-Sibling NI NI NI NI NI NI 
  S5:S5 S5:S6 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.2 0.13 * 369 376.4 0.11 * 
Parent:Offspring 67 60.1 -0.06 67 63 -0.11 
Sibling 3 3.3 -0.06 3 4.2 -0.34 
Half-Sibling NI NI NI NI NI NI 
  S6:S1 S6:S2 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.4 0.08 369 370.3 0.05 
Parent:Offspring 67 68.3 -0.04 67 68.5 -0.10 
Sibling 3 4.3 -0.32 3 2.8 0.43 *** 
Half-Sibling NI NI NI NI NI NI 
  S6:S3 S6:S4 
  count equiv count correlation count equiv count correlation 
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Mother:Father 369 369.8 0.08 369 369.7 0.11 * 
Parent:Offspring 67 68.4 -0.10 67 69.9 -0.06 
Sibling 3 4.4 -0.32 3 5.9 -0.69 
Half-Sibling NI NI NI NI NI NI 
  S6:S5 S6:S6 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 371.3 0.07 369 379.5 0.05 
Parent:Offspring 67 66.2 -0.07 67 68.8 -0.13 
Sibling 3 4.2 -0.34 3 4.3 -0.50 
Half-Sibling NI NI NI NI NI NI 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
NE Value is not estimable 
NI No results produced 
Standard error range for correlation values included in table: 0.0509 – 0.7417 
  S1r:S1r S1r:S2r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.1 0.13 * 369 369.1 0.12 * 
Parent:Offspring 67 62.2 0.07 67 62 -0.01 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S1r:S3r S1r:S4r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.6 0.15 ** 369 367.5 0.14 ** 
Parent:Offspring 67 62 -0.01 67 61.3 -0.14 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S1r:S5r S1r:S6r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.5 0.14 ** 369 377.7 0.15 ** 
Parent:Offspring 67 62 -0.06 67 58 -0.13 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S2r:S1r S2r:S2r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367 0.14 ** 369 368.1 0.14 ** 
Parent:Offspring 67 61.3 0.1 67 61.8 0.01 
Sibling 3 NE NE 3 NE NE 
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Half-Sibling NI NI NI NI NI NI 
  S2r:S3r S2r:S4r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 366.8 0.16 ** 369 367.5 0.15 ** 
Parent:Offspring 67 61.8 0.01 67 62 -0.12 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S2r:S5r S2r:S6r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.4 0.15 ** 369 377.7 0.17 *** 
Parent:Offspring 67 62 -0.04 67 58.6 -0.12 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S3r:S1r S3r:S2r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.3 0.12 * 369 369.3 0.14 ** 
Parent:Offspring 67 60.9 0.08 67 61.2 -0.01 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S3r:S3r S3r:S4r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.2 0.16 ** 369 367.8 0.15 ** 
Parent:Offspring 67 61.2 -0.05 67 61.4 -0.13 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S3r:S5r S3r:S6r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 367.4 0.16 ** 369 379.2 0.15 ** 
Parent:Offspring 67 61.5 -0.05 67 58 -0.13 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S4r:S1r S4r:S2r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.6 0.13 * 369 368.7 0.14 ** 
Parent:Offspring 67 61.3 0.02 67 61.8 -0.12 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S4r:S3r S4r:S4r 
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  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.5 0.15 ** 369 368.2 0.15 ** 
Parent:Offspring 67 61.8 -0.11 67 61.7 -0.10 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S4r:S5r S4r:S6r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.4 0.15 ** 369 376.9 0.17 ** 
Parent:Offspring 67 61.6 -0.14 67 58.2 -0.09 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S5r:S1r S5r:S2r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.7 0.12 * 369 368.8 0.14 ** 
Parent:Offspring 67 61.5 0.01 67 61.3 -0.12 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S5r:S3r S5r:S4r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.9 0.14 ** 369 368.1 0.15 ** 
Parent:Offspring 67 61.4 -0.12 67 62 -0.10 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S5r:S5r S5r:S6r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 368.3 0.15 ** 369 376.8 0.17 ** 
Parent:Offspring 67 62 -0.14 67 58.5 -0.10 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S6r:S1r S6r:S2r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 370.7 0.14 ** 369 370.8 0.16 ** 
Parent:Offspring 67 63.1 -0.02 67 63.1 -0.14 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S6r:S3r S6r:S4r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 369.3 0.16 ** 369 371.5 0.14 ** 
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Parent:Offspring 67 63.2 -0.14 67 63 -0.11 
Sibling 3 NE NE 3 NE NE 
Half-Sibling NI NI NI NI NI NI 
  S6r:S5r S6r:S6r 
  count equiv count correlation count equiv count correlation 
Mother:Father 369 371.6 0.14 ** 369 379.5 0.16 ** 
Parent:Offspring 67 62.8 -0.16 67 59.4 -0.11 
Sibling 3 NE NE 3 NE 1 
Half-Sibling NI NI NI NI NI NI 
* 0.01 ≤ p ≤ 0.05 
** 0.001 ≤ p ≤ 0.009 
*** p ≤ 0.0009 
NE Value is not estimable 
NI No results produced 
Standard error range for correlation values included in table: 0.0501 – 0.1311 
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